$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-037/02
출원번호 US-0396213 (1982-07-08)
발명자 / 주소
  • Eppstein Deborah A. (Los Altos CA) Fraser-Smith Elizabeth B. (Los Altos CA) Matthews Thomas R. (Los Gatos CA)
출원인 / 주소
  • Syntex (U.S.A.) Inc. (Palo Alto CA 02)
인용정보 피인용 횟수 : 793  인용 특허 : 5

초록

Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides.

대표청구항

A method for enhancing the anti-infective activity of a muramyldipeptide (MDP) compound which method comprises serial intravenous injection to an animal in need thereof an anti-infective enhancing amount of unencapsulated MDP compound and liposomes within three hours of each other wherein said MDP c

이 특허에 인용된 특허 (5)

  1. Baldeschwieler John D. (Pasadena CA) Gamble Ronald C. (Pasadena CA) Mauk Marcia R. (Vancouver NJ CAX) Shen Tsung-Ying (Westfield NJ) Ponpipom Mitree M. (Branchburg NJ), Lipid vesicles bearing carbohydrate surfaces as lymphatic directed vehicles for therapeutic and diagnostic substances.
  2. Jones ; Gordon H. ; Moffatt ; John G. ; Nestor ; Jr. ; John J., Novel immunological adjuvant compounds and methods of preparation thereof.
  3. Schneider Michel (Geneva CHX), Process for the preparation of liposomes in aqueous solution.
  4. Adam Arlette (Palaiseau FRX) Audibert Francoise (Neuilly FRX) Chedid Louis (Paris FRX) Choay Jean (Paris FRX) Ciorbaru Rita (Montrouge FRX) Ellouz Fabrielle (Bagneux FRX) Juy Dominique (Paris FRX) Le, Water soluble agents effective as immunological adjuvants for stimulating in the host the immune response to various ant.
  5. Adam Arlette (Palaiseau FRX) Audibert Francoise (Neuilly FRX) Chedid Louis (Paris FRX) Choay Jean (Paris FRX) Ciorbaru Rita (Montrouge FRX) Ellouz Fabrielle (Bagneux FRX) Juy Dominique (Paris FRX) Le, Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various an.

이 특허를 인용한 특허 (793)

  1. Ortega Muñoz, Alberto; Fyfe, Matthew Colin Thor; Martinell Pedemonte, Marc; Estiarte Martinez, Maria de los Angeles; Valls Vidal, Nuria; Kurz, Guido; Castro Palomino Laria, Julio Cesar, (Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors.
  2. Ortega Muñoz, Alberto; Fyfe, Matthew Colin Thor; Martinell Pedemonte, Marc; Estiarte Martinez, Maria de los Àngeles; Valls Vidal, Nuria; Kurz, Guido; Castro Palomino Laria, Julio Cesar, (Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors.
  3. Ortega Muñoz, Alberto; Fyfe, Matthew Colin Thor; Martinell Pedemonte, Marc; Estiarte Martinez, Maria de los Àngeles; Valls Vidal, Nuria; Kurz, Guido; Castro Palomino Laria, Julio Cesar, (Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors.
  4. Ortega Muñoz, Alberto; Fyfe, Matthew Colin Thor; Martinell Pedemonte, Marc; Estiarte Martinez, Maria de los Àngeles; Valls Vidal, Nuria; Kurz, Guido; Castro Palomino Laria, Julio Cesar, (Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors.
  5. Ortega Muñoz, Alberto; Fyfe, Matthew Colin Thor; Martinell Pedemonte, Marc; Estiarte Martínez, María de los Ángeles; Valls Vidal, Nuria; Kurz, Guido; Castro Palomino Laria, Julio Cesar, (Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors.
  6. Sikorski,James A.; Meng,Charles Q.; Weingarten,M. David, 1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders.
  7. Gosselin, Gilles; Storer, Richard; LaColla, Paola; Sommadossi, Jean Pierre, 2' and 3'-nucleoside prodrugs for treating infections.
  8. Sommadossi, Jean Pierre; LaColla, Paolo; Gosselin, Gilles, 2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections.
  9. Sommadossi,Jean Pierre; LaColla,Paolo; Gosselin,Gilles, 2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections.
  10. LaColla, Paola; Sommadossi, Jean-Pierre; Gosselin, Gilles, 2′ and 3′-nucleoside prodrugs for treating infections.
  11. Sommadossi, Jean-Pierre; LaColla, Paolo; Standring, David N.; Bichko, Vadim; Qu, Lin, 2′-branched nucleosides and Flaviviridae mutation.
  12. Sommadossi, Jean-Pierre; LaColla, Paolo; Standring, David; Bichko, Vadim; Qu, Lin, 2′-branched nucleosides and Flaviviridae mutation.
  13. Halperin, José A.; Natarajan, Amarnath; Aktas, Huseyin; Fan, Yun-Hua; Chen, Han, 3-3-di-substituted-oxindoles as inhibitors of translation initiation.
  14. Halperin, José A.; Natarajan, Amarnath; Aktas, Huseyin; Fan, Yun-Hua; Chen, Han, 3-3-di-substituted-oxindoles as inhibitors of translation initiation.
  15. Halperin, José A.; Natarajan, Amarnath; Aktas, Huseyin; Fan, Yun-Hua; Chen, Han, 3-3-di-substituted-oxindoles as inhibitors of translation initiation.
  16. Halperin, José A.; Natarajan, Amarnath; Aktas, Bertal Huseyin; Fan, Yun-Hua; Chen, Han, 3-3-di-substituted-oxindoles as inhibitors of translation initiation.
  17. Halperin, José A.; Natarajan, Amarnath; Aktas, Huseyin; Fan, Yun-Hua; Chen, Han, 3-3-di-substituted-oxindoles as inhibitors of translation initiation.
  18. Chu Chung K. (Athens GA) Schinazi Raymond F. (Tucker GA), 3′-Azido-2′,3′-dideoxyuridine anti-retroviral composition.
  19. Hartmann, Gunther; Schlee, Martin, 5′ triphosphate oligonucleotide with blunt end and uses thereof.
  20. Hartmann, Gunther; Schlee, Martin, 5′ triphosphate oligonucleotide with blunt end and uses thereof.
  21. Hartmann, Gunther; Schlee, Martin, 5′ triphosphate oligonucleotide with blunt end and uses thereof.
  22. Hartmann, Gunther; Schlee, Martin, 5′ triphosphate oligonucleotide with blunt end and uses thereof.
  23. LeBowitz, Jonathan; Maga, John, Acid alpha-glucosidase and fragments thereof.
  24. Lowman, Henry Bernard; Desnoyers, Luc Roland; Liu, Shouchun; West, James William; Sagert, Jason Gary; Vasiljeva, Olga; Menendez, Elizabeth-Edna Mary, Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof.
  25. Lowman, Henry Bernard; Desnoyers, Luc Roland; Liu, Shouchun; West, James William; Sagert, Jason Gary; Vasiljeva, Olga; Menendez, Elizabeth-Edna Mary, Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof.
  26. Lowman, Henry Bernard; Desnoyers, Luc Roland; Liu, Shouchun; West, James William; Sagert, Jason Gary; Vasiljeva, Olga; Menendez, Elizabeth-Edna Mary, Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof.
  27. Hostetler, Karl Y.; Beadle, James R.; Valiaeva, Nadejda, Acyclic nucleoside phosphonate diesters.
  28. Hostetler, Karl Y.; Beadle, James R.; Valiaeva, Nadejda, Acyclic nucleoside phosphonate diesters.
  29. Hostetler, Karl Y.; Beadle, James R.; Valiaeva, Nadejda, Acyclic nucleoside phosphonate diesters.
  30. Hostetler, Karl Y.; Beadle, James R.; Valiaeva, Nadejda, Acyclic nucleoside phosphonate diesters.
  31. Van Nest Gary ; Ott Gary ; Barchfeld Gail, Adjuvant formulation comprising a submicron oil droplet emulsion.
  32. Siddiqui-Jain, Adam; Bearss, David J., Alvocidib prodrugs having increased bioavailability.
  33. Kong,Xianqi; Wu,Xinfu; Migneault,David, Amidine derivatives for treating amyloidosis.
  34. Schostarez, Heinrich Josef; Chrusciel, Robert Alan, Aminediols for the treatment of Alzheimer's disease.
  35. Schostarez,Heinrich Josef; Chrusciel,Robert Alan, Aminediols for the treatment of Alzheimer's disease.
  36. Pedram, Bijan; Van Oeveren, Cornelis Arjan; Zhi, Lin; Zhao, Shuo; Shen, Yixing, Androgen receptor modulator compounds.
  37. Zhi, Lin; Higuchi, Robert I.; Van Oeveren, Cornelis Arjan; Lau, Thomas Lot Stevens, Androgen receptor modulator compounds and methods.
  38. Zhi, Lin; Higuchi, Robert I.; Van Oeveren, Cornelis Arjan; Lau, Thomas Lot Stevens, Androgen receptor modulator compounds and methods.
  39. Zhi, Lin; Higuchi, Robert I.; Van Oeveren, Cornelis Arjan; Lau, Thomas Lot Stevens, Androgen receptor modulator compounds and methods.
  40. Pedram, Bijan; Van Oeveren, Cornelis Arjan; Zhi, Lin; Zhao, Shuo; Shen, Yixing, Androgen receptor modulator methods.
  41. Lippincott, John; Van Der Horst, Edward Thein Htun; Kim, Sun Young; Presta, Leonard G., Anti-C10orf54 antibodies and uses thereof.
  42. Sagert, Jason Gary; Tipton, Kimberly Ann; Terrett, Jonathan Alexander; Singh, Shweta; Weaver, Annie Yang; Desnoyers, Luc Roland, Anti-CD71 antibodies, activatable anti-CD71 antibodies, and methods of use thereof.
  43. Stagliano, Nancy Elizabeth; West, James William; Kamath, Kathryn; Bessette, Paul Henry; Gluck, Fred; Sagert, Jason Gary; Daugherty, Patrick, Anti-EGFR activatable antibodies.
  44. Wu, Yan; van Lookeren-Campagne, Menno; Kirchhofer, Daniel; Lipari, Michael Terry; Katschke, Jr., Kenneth J.; Moran, Paul M.; Stawicki, Scott; Liang, Wei-Ching, Anti-HtrA1 antibodies and methods of use.
  45. Freeman, Gordon J.; Ahmed, Rafi; Jones, Timothy D.; Carr, Francis J.; Gregson, James P., Anti-PD-L1 antibodies and uses therefor.
  46. Scholler, Nathalie; Zhao, Aizhi; Siegel, Donald; Coukos, George, Anti-TEM1 antibodies and uses thereof.
  47. Li, Limin; Kinch, Michael; Goldbiatt, Michael, Anti-TSG101 antibodies and their uses for treatment of viral infections.
  48. Low, Philip S.; Dimitrov, Dimiter S.; Feng, Yang; Shen, Jiayin, Anti-human folate receptor beta antibodies and methods of use.
  49. Low, Philip S.; Dimitrov, Dimiter S.; Feng, Yang; Shen, Jiayin, Anti-human folate receptor beta antibodies and methods of use.
  50. Bates, Paula J.; Malik, Mohammad Tariq; Kang, Kyung A., Anti-nucleolin agent-conjugated nanoparticles.
  51. Coukos, George; Li, Chunsheng, Anti-tumor endothelial marker-1 (TEM1) antibody variants and uses thereof.
  52. Agnew, Brian; Graham, David; Singh, Upinder; Grecian, Scott, Anti-viral azide containing compounds.
  53. Agnew, Brian; Graham, David; Singh, Upinder; Grecian, Scott, Anti-viral azide containing compounds.
  54. Agnew, Brian; Singh, Upinder; Grecian, Scott, Anti-viral azide containing compounds.
  55. Guiles, Joseph; Jarvis, Thale; Strong, Sarah; Sun, Xicheng; Qiu, Jian; Rohloff, John C., Antibacterial amide and sulfonamide substituted heterocyclic urea compounds.
  56. Guiles, Joseph; Jarvis, Thale; Strong, Sarah; Sun, Xicheng; Qiu, Jian; Rohloff, John C., Antibacterial sulfone and sulfoxide substituted heterocyclic urea compounds.
  57. Guiles, Joseph; Jarvis, Thale; Strong, Sarah; Sun, Xicheng, Antibacteriall heterocyclic ureas.
  58. Chamorro Pérez, Sonia; Franco Villanueva, Ana; García Sanz, José Alberto; Kremer Barón, Leonor; Martínez Alonso, Carlos; Vela Cuenca, Maria; Carramolino Fitera, Laura, Antibodies against CCR9 and methods of use thereof.
  59. Marasco, Wayne A.; Sui, Jianhua; Xu, Chen, Antibodies against CXCR4 and methods of use thereof.
  60. Sahin, Ugur; Türeci, Özlem; Mitnacht-Kraus, Rita; Wöll, Stefan, Antibodies against Claudin 18.2 useful in cancer diagnosis.
  61. Marasco, Wayne; Sui, Jianhua, Antibodies against SARS-CoV and methods of use thereof.
  62. Schebye, Xiao Min; Selby, Mark J.; Han, Michelle Minhua; Bee, Christine; Deng, Andy X.; Chuntharapai, Anan; Devaux, Brigitte; Li, Huiming; Sheppard, Paul O.; Korman, Alan J.; Ardourel, Daniel F.; Deyanova, Ekaterina; Huang, Richard; Chen, Guodong; Kuhne, Michelle; Troung, Hong-An, Antibodies against TIM3 and uses thereof.
  63. Schebye, Xiao Min; Selby, Mark J.; Han, Michelle Minhua; Bee, Christine; Deng, Andy X.; Chuntharapai, Anan; Devaux, Brigitte; Li, Huiming; Sheppard, Paul O.; Korman, Alan J.; Ardourel, Daniel F.; Deyanova, Ekaterina; Huang, Richard; Chen, Guodong; Kuhne, Michelle; Troung, Hong-An, Antibodies against TIM3 and uses thereof.
  64. Sahin, Ugur; Tureci, Ozlem; Mitnacht-Kraus, Rita; Woll, Stefan, Antibodies against claudin 18.2 useful in cancer diagnosis.
  65. Sidhu, Sachdev; Gakhal, Amandeep; Pan, Guohua; Moffat, Jason; Robitaille, Melanie; Angers, Stephane, Antibodies against frizzled receptor.
  66. Valge Archer,Viia; Williams,Andrew James; Young,Deborah A.; Whitters,Matthew J.; Collins,Mary; Witek,Joann, Antibodies against human or mouse IL-21 receptor.
  67. Marasco, Wayne A.; Sui, Jianhua; Liddington, Robert C., Antibodies against influenza virus and methods of use thereof.
  68. Desnoyers, Luc Roland; Liang, Tony W.; Weaver, Annie Yang, Antibodies that bind activatable antibodies and methods of use thereof.
  69. Stennicke, Vibeke Westphal; Read, Christine Brender; Grell, Susanne Nedergaard; Wiberg, Charlotte; Salbo, Rune; Henriksen, Anette; Padkjaer, Soeren, Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1).
  70. Stennicke, Vibeke Westphal; Read, Christine Brender; Grell, Susanne Nedergaard; Wiberg, Charlotte; Salbo, Rune; Henriksen, Anette; Padkjaer, Soeren, Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1).
  71. Stennicke, Vibeke Westphal; Read, Christine Brender; Grell, Susanne Nedergaard; Wiberg, Charlotte; Salbo, Rune; Henriksen, Anette; Padkjaer, Soeren, Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1).
  72. Rotello, Rocco Jamie; Peters, Kevin Gene; Davis, Michael Glenn, Antibodies that bind human protein tyrosine phosphatase beta (HPTPbeta) and uses thereof.
  73. Stennicke, Vibeke Westphal; Read, Christine Brender; Kuijper, Joseph Leon; Tang, Xiaoting; Heipel, Mark; Hjorth, Siv Annegrethe, Antibodies that bind peptidoglycan recognition protein 1.
  74. Stennicke, Vibeke Westphal; Read, Christine Brender; Kuijper, Joseph Leon; Tang, Xiaoting; Heipel, Mark; Hjorth, Siv Annegrethe, Antibodies that bind peptidoglycan recognition protein 1.
  75. TenHoor, Christopher; Muruganandam, Arumugam; Ladner, Robert Charles; Wood, Clive; Bitonti, Alan J.; McGivney, James; McDonnell, Kevin; Liu, Liming; Dumont, Jennifer; Sato, Aaron K.; Viswanathan, Malini, Antibodies to FeRn and uses thereof.
  76. Tureci, Ozlem; Sahin, Ugur; Koslowski, Michael; Fritz, Stephan; Geppert, Harald-Gerhard, Antibody to genetic products differentially expressed in tumors and the use thereof.
  77. Nichols,Daniel A.; Hicks,Rickey P.; Bhattacharjee,Apurba K., Antimalarial and antiproliferative pharmacophore models, novel tryptanthrin compounds having increased solubility, and methods of making and using thereof.
  78. Duffy, Erin M.; Bhattacharjee, Ashoke; O'Dowd, Hardwin; Chen, Shili; DeVivo, Marco; Lou, Rongliang; Wimberly, Brian T., Antimicrobial compounds and methods of making and using the same.
  79. Duffy, Erin M.; Bhattacharjee, Ashoke; O'Dowd, Hardwin; Chen, Shili; DeVivo, Marco; Lou, Rongliang; Wimberly, Brian T., Antimicrobial compounds and methods of making and using the same.
  80. Duffy, Erin M.; Bhattacharjee, Ashoke; O'Dowd, Hardwin; Chen, Shili; Devivo, Marco; Lou, Rongliang; Wimberly, Brian T., Antimicrobial compounds and methods of making and using the same.
  81. Duffy, Erin M.; Bhattacharjee, Ashoke; O'Dowd, Hardwin; DeVivo, Marco; Du, Yanming; Sinishtaj, Sandra; Tang, Yuanqing; Wimberly, Brian T., Antimicrobial compounds and methods of making and using the same.
  82. Duffy, Erin M.; Bhattacharjee, Ashoke; O'Dowd, Hardwin; DeVivo, Marco; Du, Yanming; Sinishtaj, Sandra; Tang, Yuanqing; Wimberly, Brian T., Antimicrobial compounds and methods of making and using the same.
  83. Kanyo, Zoltan F.; Bhattacharjee, Ashoke, Antimicrobial compounds and methods of making and using the same.
  84. Kanyo, Zoltan F.; Bhattacharjee, Ashoke; Duffy, Erin M.; Marra, Andrea, Antimicrobial compounds and methods of making and using the same.
  85. Andersen,Raymond J.; Roberge,Michel; Britton,Robert A.; De Silva,E. Dilip, Antimitotic eleuthesides.
  86. Cathers, Brian E.; Correa, Matthew Daniel; Hansen, Joshua; Lopez-Girona, Antonia; Khalil, Ehab M.; MacBeth, Kyle; Man, Hon-Wah; Muller, George W.; Pourdehnad, Michael; Raheja, Raj, Antiproliferative compounds and methods of use thereof.
  87. Cathers, Brian E.; Correa, Matthew Daniel; Hansen, Joshua; Lopez-Girona, Antonia; Khalil, Ehab M.; MacBeth, Kyle; Man, Hon-Wah; Muller, George W.; Pourdehnad, Michael; Raheja, Raj, Antiproliferative compounds and methods of use thereof.
  88. Hansen, Joshua; Correa, Matthew Daniel; Raheja, Raj; Lopez-Girona, Antonia; Man, Hon-Wah; Muller, George W.; Khalil, Ehab M.; MacBeth, Kyle; Cathers, Brian E.; Pourdehnad, Michael, Antiproliferative compounds and methods of use thereof.
  89. Alexander, Matthew D.; Correa, Matthew D.; Hansen, Joshua; Raheja, Raj Kumar; Sapienza, John, Antiproliferative compounds, and their pharmaceutical compositions and uses.
  90. Alexander, Matthew D.; Correa, Matthew D.; Hansen, Joshua; Raheja, Raj Kumar; Sapienza, John, Antiproliferative compounds, and their pharmaceutical compositions and uses.
  91. Qiu, Xiao-Qing, Antiviral bifunctional molecules, methods of construction and methods of treating virus-induced cancer therewith.
  92. Bruce J. Bryan ; Stephen Gaalema ; Randall B. Murphy, Apparatus and method for detecting and identifying infectious agents.
  93. Bryan, Bruce J.; Gaalema, Stephen; Murphy, Randall B., Apparatus and method for detecting and identifying infectious agents.
  94. Bryan, Bruce J.; Gaalema, Stephen; Murphy, Randall B., Apparatus and method for detecting and identifying infectious agents.
  95. Wilson, D. Travis; Lerman, Lilach O.; Textor, Stephen C., Aromatic-cationic peptides and methods for using same.
  96. Ortega Muñoz, Alberto; Fyfe, Matthew Colin Thor; Martinell Pedemonte, Marc; Tirapu Fernandez De La Cuesta, Iñigo; Estiarte Martinez, Maria de los Ángeles, Arylcyclopropylamine based demethylase inhibitors of LSD1 and their medical use.
  97. Ortega Muñoz, Alberto; Fyfe, Matthew Colin Thor; Martinell Pedemonte, Marc; Tirapu Fernandez De La Cuesta, Iñigo; Estiarte-Martinez, Maria de los Ángeles, Arylcyclopropylamine based demethylase inhibitors of LSD1 and their medical use.
  98. Ortega Muñoz, Alberto; Fyfe, Matthew Colin Thor; Martinell Pedemonte, Marc; Tirapu Fernandez de la Cuesta, Iñigo; Estiarte-Martínez, Maria de los Ángeles, Arylcyclopropylamine based demethylase inhibitors of LSD1 and their medical use.
  99. Korsmeyer, Stanley J.; Letai, Anthony, BH3 peptides and method of use thereof.
  100. Korsmeyer, Stanley J.; Letai, Anthony, BH3 peptides and method of use thereof.
  101. Korsmeyer, Stanley J.; Letai, Anthony, BH3 peptides and methods of use thereof.
  102. Yusibov, Vidadi; Mett, Vadim; Musiychuck, Konstantin; Skarjinskaia, Marina, Bacillus anthracis antigens, vaccine compositions, and related methods.
  103. Aquino,Jose; John,Varghese; Tucker,John; Hom,Roy; Pulley,Shon; Tenbrink,Ruth, Benzamide 2-hydroxy-3-diaminoalkanes.
  104. Petasis, Nicos A., Benzo lipoxin analogues.
  105. Petasis, Nicos A., Benzo lipoxin analogues.
  106. Petasis, Nicos A., Benzo lipoxin analogues.
  107. Petasis, Nicos A., Benzo lipoxin analogues.
  108. Campos, Sebastien Andre; Harling, John David; Miah, Afjal Hussain; Smith, Ian Edward David, Benzothiophene derivatives as estrogen receptor inhibitors.
  109. Gordon, Eric M.; Freund, John; Gallop, Mark A.; Duncton, Matthew Alexander James, Beta-lactamase inhibitors and uses thereof.
  110. Spiegel, David; Parker, Christopher, Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus.
  111. Spiegel, David; Parker, Christopher, Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus.
  112. Bryan Bruce, Bioluminescent novelty items.
  113. Bryan Bruce, Bioluminescent novelty items.
  114. Bryan Bruce, Bioluminescent novelty items.
  115. Bryan Bruce, Bioluminescent novelty items.
  116. Chan, Ming Fai; Kogan, Timothy; Verner, Erik Joel; Kois, Adam; Balaji, Vitukudi Narayanaiyengar, Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin.
  117. Ballatore, Carlo; Castellino, Angelo J; Smith, III, Amos B; Desharnais, Joel; Sun, Chengzao; Aspland, Simon E, C-10 carbamates of taxanes.
  118. Cojocaru, Gady S.; Rotman, Galit; Levine, Zurit; Dassa, Liat; Levi, Ofer; Briante, Raffaella; Singh, Shweta; Watson, Susan R.; Pergam, Tania, C10RF32 antibodies, and uses thereof for treatment of cancer.
  119. Fox, Judith A.; Harding, Fiona A.; Harunur, Rashid M.; Schellenberger, Volker, CAB molecules.
  120. Fox, Judith A.; Harding, Fiona A.; Harunur, Rashid M.; Schellenberger, Volker, CAB molecules.
  121. Eckelman, Brendan; Timmer, John; Razai, Amir; Deveraux, Quinn; Jones, Kyle; Nguy, Peter L., CD47 antibodies and methods of use thereof.
  122. Eckelman, Brendan; Timmer, John; Razai, Amir; Deveraux, Quinn; Jones, Kyle; Nguy, Peter L., CD47 antibodies and methods of use thereof.
  123. Zhang, Jian; Armer, Thomas A., Cabergoline derivatives.
  124. Cutler, Jim E.; Han, Yongmoon, Candida albicans phosphomannan complex as a vaccine.
  125. Jim E. Cutler ; Yongmoon Han, Candida albicans phosphomannan complex as a vaccine.
  126. Carliss, Richard; Lee, David A. H., Carbinols for the treatment of neuropathic dysfunction.
  127. Marasco, Wayne A.; Lo, Agnes; Xu, Chen, Carbonic anhydrase IX (G250) anitbodies.
  128. Blahut, Eric, Cell and tissue culture container.
  129. Ferber, Sarah, Cell populations, methods of transdifferentiation and methods of use thereof.
  130. Smith, R. Lane; Tarrant, Laurence J. B.; Kusanagi, Akihiko; Claesson, Hans P. I., Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof.
  131. Sikorski,James A.; Meng,Charles Q.; Weingarten,M. David; Worsencroft,Kimberly J.; Ni,Liming, Chalcone derivatives and their use to treat diseases.
  132. Kahne, Daniel Evan; Kahne, Suzanne Walker; Doud, Emma; Gampe, Christian M.; Tsukamoto, Hirokazu, Chemoenzymatic methods for synthesizing moenomycin analogs.
  133. Girard, Jean-Philippe; Roussigne, Myriam; Amalric, Francois, Chemokine-binding protein and methods of use.
  134. Girard, Jean-Philippe; Roussigne, Myriam; Amalric, Francois, Chemokine-binding protein and methods of use.
  135. Marasco, Wayne A.; Lo, Agnes; Xu, Chen, Chimeric T cell receptor comprising carbonic anhydrase IX (G250) antibody.
  136. Ford, Byron D., Chimeric neuregulins and method of making and use thereof.
  137. Ford, Byron D., Chimeric neuregulins and method of making and use thereof.
  138. Spiegel, David; Murelli, Ryan; Zhang, Andrew, Chimeric small molecules for the recruitment of antibodies to cancer cells.
  139. Spiegel, David; Murelli, Ryan; Zhang, Andrew, Chimeric small molecules for the recruitment of antibodies to cancer cells.
  140. Spiegel, David; Murelli, Ryan; Zhang, Andrew, Chimeric small molecules for the recruitment of antibodies to cancer cells.
  141. Spiegel, David; Murelli, Ryan; Zhang, Andrew, Chimeric small molecules for the recruitment of antibodies to cancer cells.
  142. St-Arnaud, Rene, Cloned transmembrane receptor for 24-hydroxylated vitamin D compounds and uses thereof.
  143. St-Arnaud, Rene, Cloned transmembrane receptor for 24-hydroxylated vitamin D compounds and uses thereof.
  144. St-Arnaud, Rene, Cloned transmembrane receptor for 24-hydroxylated vitamin D compounds and uses thereof.
  145. St-Arnaud, Rene, Cloned transmembrane receptor for 24-hydroxylated vitamin D compounds and uses thereof.
  146. Mooney, David J.; Yuen, William W.; Arany, Praveen, Co-delivery of stimulatory and inhibitory factors to create temporally stable and spatially restricted zones.
  147. Furman, Phillip A.; Painter, III, George R.; Barry, David W.; Rousseau, Franck, Combination therapy to treat hepatitis B virus.
  148. Furman, Phillip A.; Painter, III, George R.; Barry, David W.; Rousseau, Franck, Combination therapy to treat hepatitis B virus.
  149. Abbadessa, Giovanni; France, Dennis S.; Chen, Chang-Rung; Chan, Thomas C. K., Combinational compositions and methods for treatment of cancer.
  150. Chan, Thomas C. K.; France, Dennis S.; Ishii, Kenichi; Pucci, Paolo, Combinational compositions and methods for treatment of cancer.
  151. Cabrera Aquino, Jose Gustavo; Segura Pacheco, Blanca Angelica, Compartmentalized method of nucleic acid delivery and compositions and uses thereof.
  152. Langecker, Peter; Steiert, Matthias; Hino, Toshiaki; Scicinksi, Jan; Paulvannan, Kumarapandian, Composite nanoparticles and uses thereof.
  153. Brown, Tracey J., Composition and method for the enhancement of the efficacy of drugs.
  154. Hangauer, Jr., David G., Composition and methods for modulating a kinase cascade.
  155. Hangauer, Jr., David G., Composition and methods for modulating a kinase cascade.
  156. Liu,Wei; Wu,Leeying; Chen,Huimin, Composition employing a novel human kinase.
  157. Vosika Gerald J. (Fargo ND) Cornelius Dennis A. (Fargo ND) Swenson Karl E. (Gahanna OH), Composition for macrophage activation.
  158. Looper, Ryan; Williams, Dustin; Jeyapalina, Sujeevini; Haussener, Travis; Sebahar, Paul R.; Reddy, Hariprasada R. Kanna, Compositions and methods comprising a biocidal polyamine.
  159. Kahne Suzanne Walker, Compositions and methods for cell transformation.
  160. Hilderbrand, Scott A.; Devaraj, Neal K.; Weissleder, Ralph, Compositions and methods for delivering a substance to a biological target.
  161. Chalberg, Thomas W.; Neitz, Jay; Neitz, Maureen, Compositions and methods for enhanced gene expression in cone cells.
  162. John, Matthias; Limmer, Stefan; Vornlocher, Hans-Peter; Kreutzer, Roland, Compositions and methods for inhibiting viral replication.
  163. Yusibov, Vidadi; Mett, Vadim; Hull, Anna, Compositions and methods for production of immunoglobulins.
  164. Harris, Roger; Wise, John, Compositions and methods for the sustained release of beta-alanine.
  165. Harris, Roger; Wise, John, Compositions and methods for the sustained release of beta-alanine.
  166. Harris, Roger; Wise, John, Compositions and methods for the sustained release of beta-alanine.
  167. Harris, Roger; Wise, John, Compositions and methods for the sustained release of beta-alanine.
  168. Harris, Roger; Wise, John, Compositions and methods for the sustained release of beta-alanine.
  169. Harris, Roger; Wise, John, Compositions and methods for the sustained release of betaalanine.
  170. Westlund, Neil; Hill, Jason; Ashwell, Mark A.; Namdev, Nivedita; Wang, Jianqiang; Ali, Syed, Compositions and methods for the treatment of cancer.
  171. Tu, Tseng-Rong; Li, Chia-Feng; Su, Sung-Hsieh; Wong, Chi-Huey; Fan, Eugene, Compositions and methods for treating allergies, auto-immune diseases, and improving skin condition by ganoderma lucidum (reishi) polysaccharides.
  172. Hsu, Stephen D., Compositions and methods for treating herpes simplex virus.
  173. Feener, Edward P.; Aiello, Lloyd P., Compositions and methods for treating vascular permeability.
  174. Wilson, D. Travis, Compositions and methods for treating vitiligo.
  175. Li, Chiang J.; Ashwell, Mark A.; Hill, Jason; Moussa, Magdi M.; Munshi, Neru, Compositions and methods for treatment of cancer.
  176. Li, Chiang J.; Ashwell, Mark A.; Hill, Jason; Moussa, Magdi M.; Munshi, Neru, Compositions and methods for treatment of cancer.
  177. Li, Chiang J.; Ashwell, Mark A.; Hill, Jason; Moussa, Magdi M.; Munshi, Neru, Compositions and methods for treatment of cancer.
  178. Li, Chiang J.; Ashwell, Mark A.; Hill, Jason; Moussa, Magdi; Munshi, Neru, Compositions and methods for treatment of cancer.
  179. Shen, Enyun; Ren, Shiqi, Compositions and methods related to the prevention and treatment of rabies infection.
  180. Looper, Ryan; Williams, Dustin; Jeyapalina, Sujeevini; Haussener, Travis; Sebahar, Paul R.; Reddy, Hari Kanna, Compositions comprising a biocidal polyamine.
  181. Looper, Ryan; Williams, Dustin; Jeyapalina, Sujeevini; Haussener, Travis; Sebahar, Paul R.; Reddy, Hariprasada R. Kanna, Compositions comprising a biocidal polyamine.
  182. Liu,Wei; Wu,Leeying, Compositions employing a novel human kinase.
  183. Liu,Wei; Wu,Leeying; Ford,Roger; Be,Xiaobing, Compositions employing a novel human protein phosphatase.
  184. McCord, Joe Milton; MyHill, Paul R., Compositions for alleviating inflammation and oxidative stress in a mammal.
  185. Myhill, Paul R.; Driscoll, William J., Compositions for alleviating inflammation and oxidative stress in a mammal.
  186. Myhill, Paul R.; Driscoll, William J., Compositions for alleviating inflammation and oxidative stress in a mammal.
  187. Myhill,Paul R.; Driscoll,William J., Compositions for alleviating inflammation and oxidative stress in a mammal.
  188. Kensil,Charlotte A., Compositions of CPG and saponin adjuvants and uses thereof.
  189. Kensil, Charlotte A., Compositions of CpG and saponin adjuvants and uses thereof.
  190. Shapiro, Leland, Compositions of, and methods for, alpha-1 anti trypsin Fc fusion molecules.
  191. Shapiro, Leland, Compositions of, and methods for, alpha-1 antitrypsin Fc fusion molecules.
  192. Schall, Thomas J.; Miao, Zhenhua; Berahovich, Robert; Wei, Zheng; Howard, Maureen; Premack, Brett, Compositions useful as ligands for the formyl peptide receptor like 1 receptor and methods of use thereof.
  193. Dinarello, Charles; Crapo, James D; Kim, Soohyun, Compositions, methods and uses for alpha-1 antitrypsin fusion molecules.
  194. Liu,Wei; Wu,Leeying, Compositions, organisms and methodologies employing a novel human kinase.
  195. Campos, Sebastien Andre; Harling, John David, Compounds.
  196. Graef, Isabella A.; Alhamadsheh, Mamoun M., Compounds and compositions that bind and stabilize transthyretin and their use for inhibiting transthyretin amyloidosis and protein-protein interactions.
  197. Graef, Isabella A.; Alhamadsheh, Mamoun M., Compounds and compositions that bind and stabilize transthyretin and their use for inhibiting transthyretin amyloidosis and protein-protein interactions.
  198. Graef, Isabella A.; Alhamadsheh, Mamoun M., Compounds and compositions that bind and stabilize transthyretin and their use for inhibiting transthyretin amyloidosis and protein-protein interactions.
  199. Biftu Tesfaye ; Scannell Ralph ; Cai Xiong ; Hussoin Sajjat, Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders.
  200. Biftu Tesfaye ; Scannell Ralph ; Cai Xiong ; Hussoin Sajjat, Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders.
  201. Cai Xiong (Framingham MA) Fura Aberra (Cambridge MA) Qian Changgeng (Wayland MA), Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders.
  202. Cai, Xiong; Fura, Aberra; Qian, Changgeng, Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders.
  203. Tesfaye Biftu ; Xiong Cai ; Sajjat Hussoin ; Gurmit Grewal ; T Y Shen, Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders.
  204. Cai Xiong ; Hussoin Sajjat ; Hwang San-Bao ; Killian David ; Shen T. Y., Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygen.
  205. Cai Xiong ; Hussoin Sajjat ; Hwang San-Bao ; Killian David ; Shen T. Y., Compounds and methods for the treatment of inflammatory and immune disorders.
  206. Wagner, Steven L.; Cheng, Soan; Mobley, William C.; Tanzi, Rudolph E., Compounds and uses thereof in modulating levels of various amyloid beta peptide alloforms.
  207. Cubillos-Ruiz, Juan R.; Glimcher, Laurie H., Compounds for inducing anti-tumor immunity and methods thereof.
  208. Pinegin Boris Vladimirovich,RUX, Compounds for medicinal use.
  209. Finberg, Robert W.; Kurt-Jones, Evelyn A.; Zhou, Shenghua, Compounds for modulating TLR2.
  210. Finberg, Robert W.; Kurt-Jones, Evelyn A.; Zhou, Shenghua, Compounds for modulating TLR2.
  211. Fang,Lawrence; John,Varghese, Compounds for the treatment of Alzheimer's disease.
  212. Brown, Sean P.; Li, Yunxiao; Taygerly, Joshua; Vimolratana, Marc; Wang, Xianghong; Zancanella, Manuel, Compounds that inhibit MCL-1 protein.
  213. Brown, Sean P.; Li, Yunxiao; Lizarzaburu, Mike Elias; Lucas, Brian S.; Paras, Nick A.; Taygerly, Joshua; Vimolratana, Marc; Wang, Xianghong; Yu, Ming; Zancanella, Manuel; Zhu, Liusheng; Gonzalez Buenrostro, Ana; Li, Zhihong, Compounds that inhibit Mcl-1 protein.
  214. Beck, James; Gailunas, Andrea; Hom, Roy; Jagodinska, Barbara; John, Varghese; Maillaird, Michael, Compounds to treat Alzheimer's disease.
  215. Beck,James P.; Fang,Lawrence Y.; Freskos,John N.; Gailunas,Andrea; Hom,Roy; Jagodzinska,Barbara; John,Varghese; Maillard,Michel; Pulley,Shon R.; TenBrink,Ruth E., Compounds to treat Alzheimer's disease.
  216. Fang,Lawrence Y.; John,Varghese, Compounds to treat Alzheimer's disease.
  217. Hom, Roy; Mamo, Shumeye S.; Tung, Jay; Gailunas, Andrea; John, Varghese; Fang, Lawrence Y., Compounds to treat Alzheimer's disease.
  218. Hom,Roy; Mamo,Shumeye S.; Tung,Jay; Gailunas,Andrea; John,Varghese; Fang,Lawrence Y., Compounds to treat Alzheimer's disease.
  219. Hom,Roy; Mamo,Shumeye; Tung,Jay; Gailunas,Andrea; John,Varghese; Fang,Lawrence, Compounds to treat Alzheimer's disease.
  220. Beck, James P.; Gailunas, Andrea; Hom, Roy; Jagodzinska, Barbara; John, Varghese; Maillard, Michel, Compounds to treat alzheimer's disease.
  221. Esposito, Luke A.; Hudson, F. Michael; Lake, Thomas; Cummings, Joel; Weigele, Manfred; Snow, Alan D.; Larsen, Lesley, Compounds, compositions and methods for the treatment of beta-amyloid diseases and synucleinopathies.
  222. Lindquist, Susan L.; Outeiro, Tiago; Labaudinière, Richard, Compounds, compositions and methods of inhibiting alpha-synuclein toxicity.
  223. Esposito, Luke A.; Hudson, F. Michael; Lake, Thomas; Cummings, Joel; Weigele, Manfred; Snow, Alan D., Compounds, compositions, and methods for the treatment of β-amyloid diseases and synucleinopathies.
  224. Bhatt, Ramesh; Horowitz, Lawrence; Xu, Li, Constructs and libraries comprising antibody surrogate light chain sequences.
  225. Mooney, David J.; Ali, Omar Abdel-Rahman; Dranoff, Glenn, Continuous cell programming devices.
  226. Boppart, Stephen A.; Xu, Chenyang, Contrast enhanced spectroscopic optical coherence tomography.
  227. Ali, Omar Abdel-Rahman; Dranoff, Glenn; Mooney, David J., Controlled delivery of TLR agonists in structural polymeric devices.
  228. Ali, Omar Abdel-Rahman; Dranoff, Glenn; Mooney, David J., Controlled delivery of TLR3 agonists in structural polymeric devices.
  229. Wang, Xuefeng; Cui, Jing Z.; Matsubara, Joanne A., Copper chelators for treating ocular inflammation.
  230. Ran, Chongzhao; Zhang, Xueli; Moore, Anna, Curcumin analogs.
  231. Namboothiri, Irishi N. N.; Ayyagari, Narasimham; Jose, Deena, Curcumin derivatives.
  232. Ran, Chongzhao; Moore, Anna, Curcumin derivatives for amyloid-β plaque imaging.
  233. Balaji Vitukudi Narayanaiyengar ; Chan Ming Fai, Cyclic peptide surface feature mimics of endothelin.
  234. Lewis, Evan; Shwonek, Peter; Dalziel, Sean; Jumaa, Mouhannad, Cyclodextrin complexation methods for formulating peptide proteasome inhibitors.
  235. Hilderbrand, Scott A.; Varga, Balazs R.; Weissleder, Ralph, Cyclooctenes for bioorthogonol reactions.
  236. Fyfe, Matthew Colin Thor; Ortega Muñoz, Alberto; Castro-Palomino Laria, Julio; Martinell Pedemonte, Marc; Estiarte-Martinez, Maria de los Angeles; Valls Vidal, Nuria, Cyclopropylamine derivatives useful as LSD1 inhibitors.
  237. Fyfe, Matthew Colin Thor; Ortega Muñoz, Alberto; Castro-Palomino Laria, Julio; Martinell Pedemonte, Marc; Estiarte-Martinez, Maria de los Ángeles; Valls Vidal, Nuria, Cyclopropylamine derivatives useful as LSD1 inhibitors.
  238. Laria, Julio Castro-Palomino; Fyfe, Matthew Colin Thor; Pedemonte, Marc Martinell; Muñoz, Alberto Ortega; Vidal, Núrla Valls, Cyclopropylamine inhibitors of oxidases.
  239. Girard, Jean Philippe; Amalric, Francois; Roussigne, Myriam; Clouaire, Thomas, Death associated proteins, and THAP1 and PAR4 pathways in apoptosis control.
  240. Hamilton, Timothy; Goodwin, Ted E., Dental articulation kit and method.
  241. Bruce Bryan, Detection and visualization of neoplastic tissues and other tissues.
  242. Bryan, Bruce, Detection and visualization of neoplastic tissues and other tissues.
  243. Gordon, Eric M., Deuterated O-sulfated beta lactam hydroxamic acids and deuterated N-sulfated beta lactams.
  244. Gordon, Eric M., Deuterated O-sulfated beta-lactam hydroxamic acids and deuterated N-sulfated beta-lactams.
  245. Boppart, Stephen A.; Xi, Chuanwu, Device and method for imaging the ear using optical coherence tomography.
  246. Jones, Stephen N.; Liang, Huiling; Pihan, German, Diagnosing and treating hematopoietic cancers.
  247. Schostarez,Heinrich Josef; Chrusciel,Robert A., Diaminediols for the treatment of Alzheimer's disease.
  248. McMinn, Dustin; Johnson, Henry; Moebius, David C., Dipeptide and tripeptide epoxy ketone protease inhibitors.
  249. John,Varghese; Tung,Jay; Hom,Roy; Guinn,Ashley; Fang,Lawrence; Gailunas,Andrea; Mamo,Shumeye S., Dipeptide inhibitors of β-secretase.
  250. Marks, Daniel L.; Boppart, Stephen A., Distinguishing non-resonant four-wave-mixing noise in coherent stokes and anti-stokes Raman scattering.
  251. Shin, Hyeon-Cheol; Hwang, Hyejeong; Park, Kwang Yong; Kim, Seong Ho; Lee, Haengwoo, Eckol derivatives, methods of synthesis and uses thereof.
  252. Pandey,Ravindra K.; Dougherty,Thomas J.; Pallenberg,Alexander J., Efficient synthesis of pyropheophorbide a and its derivatives.
  253. Corn, Jacob E.; Zhang, Yingnan; Phillips, Aaron H., Engineered conformationally-stabilized proteins.
  254. Mooney, David J.; Borselli, Cristina; Vandenburgh, Herman; Shvartsman, Dimitry; Storrie, Hannah; Lichtman, Jeff, Enhancement of skeletal muscle stem cell engraftment by dual delivery of VEGF and IGF-1.
  255. Gillies, Stephen D.; Burger, Christa; Lo, Kin-Ming, Enhancing the circulating half-life of antibody-based fusion proteins.
  256. Gillies,Stephen D.; Burger,Christa; Lo,Kin Ming, Enhancing the circulating half-life of antibody-based fusion proteins.
  257. Gillies,Stephen D.; Burger,Christa; Lo,Kin Ming, Enhancing the circulating half-life of antibody-based fusion proteins.
  258. Livingston, James A., Enzymatic debridement therapy for abnormal cell proliferation.
  259. Armer, Thomas; McKinley, Geoff; Borland, Scott; Guzman, Miguel; Szabolcs, Ármin; Gerencser, János, Ergoline compounds and uses thereof.
  260. Armer, Thomas; McKinley, Geoff; Borland, Scott; Guzman, Miguel; Szabolcs, Ármin; Gerencser, János, Ergoline compounds and uses thereof.
  261. Armer, Thomas; McKinley, Geoff; Borland, Scott; Guzman, Miguel; Szabolcs, Ármin; Gerencser, János, Ergoline compounds and uses thereof.
  262. Armer, Thomas; McKinley, Geoff; Borland, Scott; Guzman, Miguel; Szabolcs, Ármin; Gerencser, János, Ergoline compounds and uses thereof.
  263. Way,Jeffrey, Erythropoietin forms with improved properties.
  264. Rothenberg, Marc E.; Lu, Thomas Xuefeng, Esophageal microRNA expression profiles in eosinophilic esophagitis.
  265. Rothenberg, Marc E.; Lu, Thomas Xuefeng, Esophageal microRNA expression profiles in eosinophilic esophagitis.
  266. Ruenitz Peter C., Estrogen mimetics lacking reproductive tract effects.
  267. Ruenitz, Peter C., Estrogen mimetics lacking reproductive tract effects.
  268. Crew, Andrew; Crews, Craig; Dong, Hanqing; Ko, Eunhwa; Wang, Jing, Estrogen-related receptor alpha based protac compounds and associated methods of use.
  269. Madison, Edwin L.; Thanos, Christopher, Factor VII polypeptides that are modified and uses thereof.
  270. Madison, Edwin L.; Thanos, Christopher, Factor VII polypeptides that are modified and uses thereof.
  271. Madison, Edwin L.; Thanos, Christopher, Factor VII polypeptides that are modified and uses thereof.
  272. Yuen, Kwok-Yung; Woo, Patrick Chiu-Yat; Lau, Susanna Kar-Pui, Feline morbillivirus and uses thereof.
  273. Trauger, Richard, Felinized antibodies and methods of treating retroviral infections in felines.
  274. Clark, Richard A.; Ren, Xiang-Dong; Lin, Fubao, Fibronectin polypeptides and methods of use.
  275. Lu, Zhijian; Liu, Wei; Zhang, Jimin; Yaworsky, Paul John; Olland, Stephane H.; Brown, Christopher Todd; Shen, Emily Sheng-ming, Finger-1 peptide analogs of the TGF-β superfamily.
  276. Marasco, Wayne A., Flavivirus neutralizing antibodies and methods of use thereof.
  277. Zhang,Han Zhong; Cai,Sui Xiong; Drewe,John A.; Yang,Wu, Fluorescence dyes and their applications for whole-cell fluorescence screening assays for caspases, peptidases, proteases and other enzymes and the use thereof.
  278. Pandey, Ravindra K.; Potter, William R.; Dougherty, Thomas J., Fluorinated photosensitizers related to chlorins and bacteriochlorins for photodynamic therapy.
  279. Cook, Robert O.; Zhang, Jian; Armer, Thomas A., Fluoroergoline analogs.
  280. Cook, Robert O.; Zhang, Jian; Armer, Thomas A., Fluoroergoline analogs.
  281. Cook, Robert O.; Zhang, Jian; Armer, Thomas A., Fluoroergoline analogs.
  282. Cook, Robert O.; Zhang, Jian; Armer, Thomas A., Fluoroergoline analogs.
  283. Cook, Robert O.; Zhang, Jian; Armer, Thomas A., Fluoroergoline analogs.
  284. Cook, Robert O.; Zhang, Jian; Armer, Thomas A., Fluoroergoline analogs.
  285. Weber, Eckard; Cai, Sui Xiong; Keana, John F. W.; Drewe, John A.; Zhang, Han-Zhong, Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for caspases and other enzymes and the use thereof.
  286. Weber,Eckard; Cai,Sui Xiong; Keana,John F. W.; Drewe,John A.; Zhang,Han Zhong, Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for caspases and other enzymes and the use thereof.
  287. Mustaev, Arkady; Kozlov, Maxim; Marras, Salvatore; Krasnoperov, Lev; Wirpsza, Laura; Pillai, Shyamala, Fluorophore chelated lanthanide luminescent probes with improved quantum efficiency.
  288. Mustaev, Arkady; Kozlov, Maxim; Marras, Salvatore; Krasnoperov, Lev; Wirpsza, Laura; Pillai, Shyamala, Fluorophore chelated lanthanide luminescent probes with improved quantum efficiency.
  289. LeBowitz, Jonathan; Chang, Byeong, Formulations for lysosomal enzymes.
  290. Hilderbrand, Scott A.; Devaraj, Neal K.; Weissleder, Ralph; Karver, Mark R., Functionalized 1,2,4,5-tetrazine compounds for use in bioorthogonal coupling reactions.
  291. Yu, Alice; Yu, John; Lin, Kuo-I; Yang, Wen-Bin; Wong, Chi-Huey, Fungal immunostimulatory compositions.
  292. Monod,Michel; Stocklin,Reto; Grouzmann,Eric, Fungal proteins and nucleic acids encoding same.
  293. Monod,Michel; Stocklin,Reto; Grouzmann,Eric, Fungal proteins and nucleic acids encoding same.
  294. Baden, Daniel G.; Abraham, William M.; Bourdelais, Andrea J.; Michelliza, Sophie, Fused pentacyclic polyethers.
  295. Baden, Daniel G.; Abraham, William M.; Bourdelais, Andrea J.; Michelliza, Sophie, Fused pentacyclic polyethers.
  296. Baden,Daniel G.; Abraham,William M.; Bourdelais,Andrea J., Fused pentacyclic polyethers.
  297. Tanzi, Rudolph E.; Wagner, Steven L.; Cheng, Soan; Mobley, William C., Gamma-secretase modulators.
  298. Kounnas, Maria Z.; Ackermann, Elizabeth J.; Stauderman, Kenneth A.; Velicelebi, Gonul; Wagner, Steve, Gamma-secretase modulatory compounds, methods for identifying same, and uses therefor.
  299. Wang, Wenge; Luan, Yen Tung, Glycolysis-inhibiting substances in cell culture.
  300. Kahne Daniel Evan (Princeton NJ) Kahne Suzanne Walker (Princeton NJ), Glycosylated steroid derivatives for transport across biological membranes and process for making and using same.
  301. Schinazi,Raymond F.; Hammond,Jennifer L.; Mellors,John W.; Liotta,Dennis C., HIV-1 mutations selected for by β-2',3'-didehydro-2',3'-dideoxy-5-fluorocytidine.
  302. Schinazi, Raymond F.; Hammond, Jennifer L.; Mellors, John W.; Liotta, Dennis C., HIV-1 mutations selected for by β-2',3'-didehydro-2',3'-dideoxy-5-fluorocytidine.
  303. McDonald, Ian A.; Turner, Craig Ivan; Deodhar, Mandar; Foot, Jonathan Stuart, Haloallylamine inhibitors of SSAO/VAP-1 and uses therefor.
  304. Huebsch, Nathaniel D.; Mooney, David J., Harnessing cell dynamics to engineer materials.
  305. Martin,Richard; Flatt,Brenton T; Kahl,Jeffrey D; Wang,Tie Lin, Heterocyclic modulators of nuclear receptors.
  306. Miller, Thomas A.; Witter, David J.; Belvedere, Sandro, Histone deacetylase inhibitor prodrugs.
  307. Wang, Zhirui; Huang, Christene A.; Sachs, David H., Human CTLA4 mutants and use thereof.
  308. Freeman, Gordon J.; Ahmed, Rafi; Jones, Timothy D.; Carr, Francis J.; Gregson, James P., Human anti-PD-1 antibodies and uses therefor.
  309. Freeman, Gordon J.; Ahmed, Rafi; Jones, Timothy D.; Carr, Francis J.; Gregson, James P., Human anti-PD-1, PD-L1, and PD-L2 antibodies and uses therefor.
  310. Frost, Gregory I.; Kundu, Anirban; Bookbinder, Louis H., Human chondroitinase glycoprotein (CHASEGP), process for preparing the same, and pharmaceutical compositions comprising thereof.
  311. Gimeno, Ruth E.; Kapeller-Libermann, Rosana; Wu, Zhidan; Hubbard, Brian K., Human diacylglycerol acyltransferase 2 (DGAT2) family members and uses therefor.
  312. Gimeno, Ruth E.; Wu, Zhidan; Kapeller Libermann, Rosana; Hubbard, Brian K., Human diacylglycerol acyltransferase 2 (DGAT2) family members and uses therefor.
  313. Marasco, Wayne A.; Sui, Jianhua, Human monoclonal anti-PD-L1 antibodies and methods of use.
  314. Sutkowski, Natalie; Fernandes, Daniel; Hoel, Brian; Rubinchik, Semyon, Human monoclonal antibodies to human nucleolin.
  315. Sexton, Daniel J.; Tenhoor, Christopher; Viswanathan, Malini, Human neonatal Fc receptor antibodies and methods of use thereof.
  316. Fang, Fang; Kohlstaedt, Lori; Reno, John, Humanized antibodies.
  317. Fang, Fang; Kohlstaedt, Lori; Reno, John, Humanized antibodies.
  318. Marasco, Wayne A.; Sui, Jianhua; Avnir, Yuval, Humanized monoclonal antibodies and methods of use.
  319. Brown, Tracey J., Hyaluronan as a chemo-sensitizer in the treatment of cancer.
  320. Brown, Tracey J.; Fox, Richard M., Hyaluronan as a drug pre-sensitizer and chemo-sensitizer in the treatment of disease.
  321. Brown, Tracey J., Hyaluronan-chemotherapeutic agent formulations for the treatment of colon cancer.
  322. Bookbinder, Louis H.; Kundu, Anirban; Frost, Gregory I., Hyaluronidase and factor VIII compositions.
  323. Breslow, Ronald; Miller, Thomas A.; Belvedere, Sandro; Marks, Paul A.; Richon, Victoria M.; Rifkind, Richard A., Hydroxamic acid compounds and methods of use thereof.
  324. Breslow,Ronald; Miller,Thomas A.; Belvedere,Sandro; Marks,Paul A.; Richon,Victoria M.; Rifkind,Richard A., Hydroxamic acid compounds and methods of use thereof.
  325. Freskos,John; Brown,David L.; Fobian,Yvette M.; Fang,Larry; Romero,Arthur Glenn; John,Varghese, Hydroxy alkyl amines.
  326. Tucker,John A.; Sherer,Brian A.; Xu,Ying Zi; Brogley,Louis; Pulley,Shon R.; Jacobs,Jon S.; Beck,James P.; John,Varghese, Hydroxypropyl amides for the treatment of Alzheimer's disease.
  327. Fisher,Jed F.; Jacobs,Jon S.; Sherer,Brian, Hydroxypropylamines.
  328. Ponath, Paul; Rao, Patricia; Rosenzweig, Michael; Smith, L. Mary; Ponte, Jose F., ILT3 binding molecules and uses therefor.
  329. Ponath, Paul; Rosenzweig, Michael; Ponte, Jose F., ILT3 binding molecules and uses therefor.
  330. Sahin, Ugur; Tureci, Ozlem; Koslowski, Michael; Usener, Dirk, Identification of tumor-associated antigens for diagnosis and therapy.
  331. Sahin, Ugur; Türeci, Özlem; Koslowski, Michael; Usener, Dirk, Identification of tumor-associated antigens for diagnosis and therapy.
  332. Ran, Chongzhao; Moore, Anna; Brownell, Anna-Liisa, Imaging brown adipose tissue with curcumin derivatives.
  333. Wang, Yuan Yuan; Khoo, Kay Hooi; Chen, Shui Tein; Lin, Chun Cheng; Wong, Chi Huey; Lin, Chun Hung; Chen, Hong Sen; Tsai, Yow Fu, Immuno-modulating antitumor activities of (Reishi) polysaccharides.
  334. Gillies, Stephen D.; Lo, Kin-Ming; Qian, Susan X., Immunocytokine sequences and uses thereof.
  335. Gillies, Stephen D.; Lo, Kin-Ming; Qian, Susan Xiuqi, Immunocytokine sequences and uses thereof.
  336. Gillies,Stephen D.; Lo,Kin Ming; Qian,Susan X., Immunocytokine sequences and uses thereof.
  337. Kim, Jaeyun; Mooney, David J.; Li, Weiwei Aileen; Arany, Praveen; Gadish, Or, In situ antigen-generating cancer vaccine.
  338. Stavros C. Manolagas ; Teresita Bellido, Increasing bone strength with selected bisphosphonates.
  339. Vescovi, Angelo Luigi; Reynolds, Brent Allen, Inhibition of the tumorigenic potential of tumor stem cells by LIF and BMPs.
  340. Markovitz, David; Mor-Vaknin, Nirit; Legendre, Maureen; Engelke, David; Benford, Kristine; Pai, Dave, Inhibitors of DEK protein and related methods.
  341. Bencherif, Sidi A.; Sands, Roger Warren; Koshy, Sandeep T.; Mooney, David J., Injectable cryogel vaccine devices and methods of use thereof.
  342. Bencherif, Sidi A.; Mooney, David J.; Edwards, David; Sands, Roger Warren, Injectable preformed macroscopic 3-dimensional scaffolds for minimally invasive administration.
  343. Gantier, Rene; Vega, Manuel; Drittanti, Lila; Guyon, Thierry, Interferon-β mutants with increased anti-proliferative activity.
  344. Zhang, Jian; Cook, Robert O., Iso-ergoline derivatives.
  345. Zhang, Jian; Cook, Robert O., Iso-ergoline derivatives.
  346. Zhang, Jian; Cook, Robert O., Iso-ergoline derivatives.
  347. Armer, Thomas; McKinley, Geoff; Borland, Scott; Guzman, Miguel, Isoergoline compounds and uses thereof.
  348. Armer, Thomas; McKinley, Geoff; Borland, Scott; Guzman, Miguel, Isoergoline compounds and uses thereof.
  349. Armer, Thomas; McKinley, Geoff; Borland, Scott; Guzman, Miguel, Isoergoline compounds and uses thereof.
  350. Strömberg, Roger; Honcharenko, Dmytro; Maity, Jyotirmoy; Juneja, Alok; Kurudenkandy, Firoz Roshan; Presto, Jenny; Dolfe, Lisa; Fisahn, André; Johansson, Jan; Nilsson, Lennart, Ligands for prevention of neurotoxicity of the alzheimer's disease related amyloid-beta peptide.
  351. Byra Anna ; Burzynski Stanislaw R. ; Waldbillig Robert J., Liposomal antineoplaston therapies with markedly improved antineoplastic activity.
  352. Anderson Peter M. (St. Louis Park MN) Leonard Arnold S. (Minneapolis MN) Ochoa Augusto C. (Minneapolis MN) Loeffler Cynthia (Woodbury MN), Liposome immunoadjuvants containing IL-2.
  353. Anderson Peter M. ; Leonard Arnold S. ; Ochoa Augusto C. ; Loeffler Cynthia, Lipsome containing IL-2.
  354. Boppart, Stephen A.; Nguyen, Freddy T.; Zysk, Adam M., Low-coherence interferometry and optical coherence tomography for image-guided surgical treatment of solid tumors.
  355. Hostetler, Karl Y.; Beadle, James R., Lung-targeted drugs.
  356. Hostetler, Karl Y.; Beadle, James R., Lung-targeted drugs.
  357. Ortega Muñoz, Alberto; Castro-Palomino Laria, Julio; Fyfe, Matthew Colin Thor, Lysine Specific Demethylase-1 inhibitors and their use.
  358. Baker, Jonathan A.; Fyfe, Matthew Collin Thor, Lysine demethylase inhibitors for diseases and disorders associated with Flaviviridae.
  359. Baker, Jonathan Alleman; Fyfe, Matthew Colin Thor, Lysine demethylase inhibitors for diseases and disorders associated with Hepadnaviridae.
  360. Baker, Jonathan Alleman; Castro Palomino, Julio; Fyfe, Matthew Colin Thor; Maes, Tamara; Martinell Pedemonte, Marc, Lysine demethylase inhibitors for myeloproliferative disorders.
  361. Muñoz, Alberto Ortega; Castro-Palomino Laria, Julio; Fyfe, Matthew Colin Thor, Lysine specific demethylase-1 inhibitors and their use.
  362. Muñoz, Alberto Ortega; Castro-Palomino Laria, Julio; Fyfe, Matthew Colin Thor, Lysine specific demethylase-1 inhibitors and their use.
  363. Ortega Munoz, Alberto; Castro-Palomino Laria, Julio; Fyfe, Matthew Colin Thor, Lysine specific demethylase-1 inhibitors and their use.
  364. LeBowitz, Jonathan H.; Maga, John, Lysosomal targeting peptides and uses thereof.
  365. LeBowitz, Jonathan; Maga, John, Lysosomal targeting peptides and uses thereof.
  366. Yannoni,Yvonne M.; Lin,Lih Ling, MK2 interacting proteins.
  367. Kufe, Donald W., MUC1-IκB kinase complexes and their activities.
  368. Oldenburg, Amy L.; Boppart, Stephen A.; Crecea, Vasilica; Liang, Xing, Magnetomotive optical coherence tomography.
  369. Cao, Lan; Bouhadir, Kamal H.; Mooney, David J., Materials presenting notch signaling molecules to control cell behavior.
  370. Kim, Jaeyun; Li, Weiwei Aileen; Mooney, David J., Mesoporous silica compositions for modulating immune responses.
  371. Zysk, Adam M.; Adie, Steven G.; Leigh, Matthew S.; Armstrong, Julian J.; Sampson, David D.; Boppart, Stephen A., Method and apparatus for measurement of optical properties in tissue.
  372. Szeto, Hazel; Zhao, Kesheng; Robertson, Hugh; Birk, Alex V., Method and carrier complexes for delivering molecules to cells.
  373. Newman, Gale; Jacob-Mungin, Barbara A.; Obialo, Chamberlain, Method and compositions for the treatment and detection of endothelin-1 related kidney diseases.
  374. Zeichner, Steven L.; Fernandez, Guerau, Method and compositions for treating HIV infection.
  375. Kong, Xianqi; Wu, Xinfu; Bouzide, Abderrahim; Valade, Isabelle; Migneault, David; Gervais, Francine; Delorme, Daniel; Bachand, Benoit; Atfani, Mohamed; Levesque, Sophie; Samim, Bita, Method and compositions for treating amyloid-related diseases.
  376. Eppstein Deborah A. (Palo Alto CA) Fraser-Smith Elizabeth (Los Altos CA) Matthews Thomas R. (Los Gatos CA), Method for enhancing the anti-infective activity of muramyldipeptide derivatives.
  377. Tavarekere, Girish S; Balasubramanian, Gopal, Method for identifying inhibitors of Staphylococcus aureus.
  378. LeBowitz, Jonathan H.; Beverley, Stephen M., Method for targeting lysosomal enzymes.
  379. Bates, Paula J.; Miller, Donald M.; Trent, John O.; Xu, Xiaohua, Method for the diagnosis and prognosis of malignant diseases.
  380. Bates, Paula J.; Miller, Donald M.; Trent, John O.; Xu, Xiaohua, Method for the diagnosis and prognosis of malignant diseases.
  381. Bates,Paula J.; Miller,Donald M.; Trent,John O.; Xu,Xiaohua, Method for the diagnosis and prognosis of malignant diseases.
  382. Miller, Donald M.; Bates, Paula J.; Trent, John O.; Xu, Xiaohua, Method for the diagnosis and prognosis of malignant diseases.
  383. Amara,Ali; Arenzana Seisdedos,Fernando; Despres,Philippe; Virelizier,Jean Louis, Method of inhibiting binding of Dengue virus to a human cell with DC-SIGN blockers.
  384. Himawan,Jeff, Method of producing bispecific molecules by protein trans-splicing.
  385. Qiu, Xiao-Qing, Method of producing the polypeptide for treating virus-induced cancer.
  386. Amara,Ali; Halary,Frank; Dechanet Merville,Julie; Moreau,Jean Francois; Arenzana Seisdedos,Fernando; Delaunay,Thierry, Method of treating cytomegalovirus with DC-SIGN blockers.
  387. Verner, Erik Joel, Method of treating glaucoma.
  388. Casey, John L.; Korba, Brent E.; Cote, Paul J.; Gerin, John L.; Tennant, Bud C.; Chu, Chung K., Method of treating hepatitis delta virus infection.
  389. Casey,John L.; Korba,Brent E.; Cote,Paul J.; Gerin,John L.; Tennant,Bud C.; Chu,Chung K., Method of treating hepatitis delta virus infection.
  390. Qiu, Xiao-Qing, Method of treating virus-induced cancer.
  391. Hua, Kuo-Feng; Hsu, Hsien-Yeh; Wong, Chi-Huey, Methods and compositions associated with administration of an extract of.
  392. Kim, Sung K.; Deciu, Cosmin, Methods and compositions for analyzing nucleic acid.
  393. Wilson, D. Travis, Methods and compositions for detecting and diagnosing diseases and conditions.
  394. Liu, Liping; Tang, Shibo; Liang, Xiaoling, Methods and compositions for preventing or treating ophthalmic conditions.
  395. Liu, Liping; Tang, Shibo; Liang, Xiaoling, Methods and compositions for preventing or treating ophthalmic conditions.
  396. Liu, Liping; Tang, Shibo; Liang, Xiaoling, Methods and compositions for preventing or treating ophthalmic conditions.
  397. Liu, Liping; Tang, Shibo; Liang, Xiaoling, Methods and compositions for preventing or treating ophthalmic conditions.
  398. Smith, Maree T., Methods and compositions for reducing the risk associated with the administration of opioid analgesics in patients with diagnosed or undiagnosed respiratory illness.
  399. Wilson, D. Travis; Kloner, Robert A., Methods and compositions for regulating SRCA2A expression levels in myocardial infarction.
  400. LeBowitz, Jonathan, Methods and compositions for targeting proteins across the blood brain barrier.
  401. Wilson, D. Travis; Bamberger, Mark, Methods and compositions for the prevention or treatment of barth syndrome.
  402. Ammann Arthur J. (San Rafael CA), Methods and compositions for the treatment of lung conditions.
  403. Desrosiers, Ronald; Shin, Young, Methods and compositions for transgene expression in a herpesvirus vector system.
  404. Kong, Xianqi; Migneault, David; Valade, Isabelle; Wu, Xinfu; Gervais, Francine, Methods and compositions for treating amyloid-related diseases.
  405. Kong, Xianqi; Szarek, Walter A.; Gervais, Francine, Methods and compositions for treating amyloid-related diseases.
  406. Kong, Xianqi; Wu, Xinfu; Bouzide, Abderrahim; Valade, Isabelle; Migneault, David; Gervais, Francine; Delorme, Daniel; Bachand, Benoit; Atfani, Mohamed; Levesque, Sophie; Samim, Bita, Methods and compositions for treating amyloid-related diseases.
  407. Kong,Xianqi; Migneault,David; Valade,Isabelle; Wu,Xinfu; Gervais,Francine, Methods and compositions for treating amyloid-related diseases.
  408. Kong,Xianqi; Szarek,Walter A.; Gervais,Francine, Methods and compositions for treating amyloid-related diseases.
  409. Sommadossi, Jean-Pierre; LaColla, Paolo, Methods and compositions for treating flaviviruses and pestiviruses.
  410. Sommadossi, Jean-Pierre; LaColla, Paulo, Methods and compositions for treating flaviviruses and pestiviruses.
  411. Sommadossi, Jean Pierre; LaColla, Paulo, Methods and compositions for treating hepatitis C virus.
  412. Sommadossi, Jean-Pierre; LaColla, Paulo, Methods and compositions for treating hepatitis C virus.
  413. Gosselin,Gilles; Imbach,Jean Louis; Sommadossi,Jean Pierre, Methods and compositions for treating hepatitis C virus using 4'-modified nucleosides.
  414. Kufe, Donald W., Methods and compositions relating to promoter regulation by MUC1 and KLF proteins.
  415. Kufe, Donald W., Methods and compositions relating to the regulation of MUC1 by HSF1 and STAT3.
  416. Kufe, Donald W., Methods and compositions relating to the regulation of apoptosis by MUC1 and BH3-containing proapoptotic proteins.
  417. Medford, Russell M.; Saxena, Uday, Methods and compositions to lower plasma cholesterol levels.
  418. Nichols, Pilarin Elizabeth; Luisi, Donna L., Methods and compositions with reduced opalescence.
  419. Kahne, Daniel Evan; Kahne, Suzanne Walker; Gampe, Christian M.; Tsukamoto, Hirokazu, Methods and compounds for identifying glycosyltransferase inhibitors.
  420. Szarek, Walter A.; Weaver, Donald F.; Kong, Xianqi; Gupta, Ajay; Migneault, David, Methods and compounds for inhibiting amyloid deposits.
  421. Szarek, Walter A.; Weaver, Donald F.; Kong, Xianqi; Gupta, Ajay; Migneault, David, Methods and compounds for inhibiting amyloid deposits.
  422. Szarek,Walter A.; Weaver,Donald F.; Kong,Xianqi; Gupta,Ajay; Migneault,David, Methods and compounds for inhibiting amyloid deposits.
  423. Cantor, Charles R.; DeSantis, Grace; Mueller, Reinhold; Ehrich, Mathias, Methods and processes for non-invasive assessment of genetic variations.
  424. Sherwood, Steven W., Methods for detecting targets.
  425. Twine, Natalie C.; Burczynski, Michael E.; Trepicchio, William L.; Dorner, Andrew J.; Stover, Jennifer A.; Slonim, Donna K., Methods for diagnosing RCC and other solid tumors.
  426. Myhill, Paul R.; Driscoll, William J., Methods for enhancing antioxidant enzyme activity and reducing c-reactive protein levels.
  427. Glimcher, Laurie H.; Bettigole, Sarah; Martinon, Fabio, Methods for increasing immune responses using agents that directly bind to and activate IRE-1.
  428. Nadine A. Tatton ; William G. Tatton, Methods for increasing schwann cell survival.
  429. Tatton,Nadine A.; Tatton,William G., Methods for increasing schwann cell survival.
  430. Keith, Dennis; Lai, Jan-Ji; Govardhan, Chandrika; Khalaf, Nazer, Methods for preparing purified lipopeptides.
  431. Keith, Dennis; Lai, Jan-Ji; Govardhan, Chandrika; Khalaf, Nazer, Methods for preparing purified lipopeptides.
  432. Keith, Dennis; Lai, Jan-Ji; Govardhan, Chandrika; Khalaf, Nazer, Methods for preparing purified lipopeptides.
  433. Schiller, Peter W.; Szeto, Hazel H.; Zhao, Kesheng, Methods for preventing or treating mitochondrial permeability transition.
  434. Szeto, Hazel H.; Schiller, Peter W.; Zhao, Kesheng, Methods for preventing or treating mitochondrial permeability transition.
  435. Szeto, Hazel H.; Felsen, Diane, Methods for prevention and treatment of acute renal injury.
  436. Szeto, Hazel H.; Felsen, Diane, Methods for prevention and treatment of acute renal injury.
  437. Szeto, Hazel H.; Liu, Shaoyi; Cho, Sunghee, Methods for reducing CD36 expression.
  438. Szeto, Hazel H.; Liu, Shaoyl; Cho, Sunghee, Methods for reducing CD36 expression.
  439. Carter Bruce L. A. (Mercer Island WA) Edwards Martin W. (Woodinville WA), Methods for reducing blood loss.
  440. Bookbinder, Louis; Kundu, Anirban; Frost, Gregory I., Methods for reducing intraocular pressure by administering a soluble hyaluronidase glycoprotein (sHASEGP).
  441. Szeto, Hazel, Methods for reducing oxidative damage.
  442. Szeto, Hazel H., Methods for reducing oxidative damage.
  443. Szeto, Hazel H., Methods for reducing oxidative damage.
  444. Long, Xiangtian; Dai, Danmei; Brunner, Andreas; Watt, Derek Kevin; Clinch, Keith; Baars, Sylvia Myrna; Dixon, Rachel Anne; Little, Gillian Mary; Landreau, Cyrille Abel Sébastien; Proisy, Nicolas Georges Rene, Methods for synthesizing molybdopterin precursor Z derivatives.
  445. Tompkins, Ronald G.; Tzika, A. Aria; Yu, Yong-Ming; Rahme, Laurence; Martyn, Jeevendra A., Methods for the prevention and treatment of burn injuries and secondary complications.
  446. Wilson, D. Travis; Borow, Kenneth; Kloner, Robert A.; Hale, Sharon, Methods for the prevention or treatment of no-reflow following ischemia/reperfusion injury.
  447. Wilson, D. Travis; Kloner, Robert A., Methods for the regulation of matrix metalloproteinase expression.
  448. Khalifah, Raja G.; Keilitz, Roland; Koellner, Christoph; Degenhardt, Thorsten; Brand, Stephen Robert, Methods for the synthesis of pyridoxamine.
  449. Khalifah,Raja; Keilitz,Roland; Koellner,Christoph; Degenhardt,Thorsten; Brand,Stephen Robert, Methods for the synthesis of pyridoxamine.
  450. Bookbinder, Louis H.; Kundu, Anirban; Frost, Gregory I., Methods for treating a disease characterized by an excess of hyaluronan by administering a soluble hyaluronidase glycoprotein (sHASEGP).
  451. Bookbinder, Louis; Kundu, Anirban; Frost, Gregory I., Methods for treating edema by administering a Soluble Hyaluronidase Glycoprotein (sHASEGP).
  452. Hajjar, Roger J.; Lompr, Anne-Marie; Lipskaia, Larissa; del Monte, Federica, Methods for treating restenosis.
  453. Wilson, D. Travis; Bamberger, Mark; Blakey, Brian, Methods for treatment of atherosclerosis.
  454. Wilson, D. Travis; Bamberger, Mark; Blakey, Brian; Andersen, Marc W., Methods for treatment of atherosclerosis.
  455. Chen, Yinpu; Garmey, Edward G.; Schwartz, Brian, Methods for treatment of non-small cell lung cancer.
  456. Letai, Anthony G., Methods of determining cellular chemosensitivity.
  457. Rothenberg, Marc E.; Caldwell, Julie, Methods of determining eosinophilic gastritis status based on marker or gene expression.
  458. Ferber, Sarah, Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues.
  459. Ferber, Sarah, Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues.
  460. Ferber, Sarah, Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues.
  461. Yang, Jianguo; Yang, Yang; Tengtrakool, Jennifer; Zhou, Weichang, Methods of perfusion culturing using a shake flask and microcarriers.
  462. Sexton, Daniel J.; TenHoor, Christopher; Viswanathan, Malini, Methods of producing antibodies to neonatal Fc receptor (FcRn).
  463. Cockett, Mark; Ramanathan, Chandra S.; Lodge, Nicholas J.; Fitzgerald, Kevin; Stouch, Terry; Moore, Lisa; Kindt, Rachel M.; Kopczynski, Jenny; Doberstein, Stephen Kohl, Methods of screening for agents that modulate the interaction of RGS and Gαq and urinary incontinence.
  464. Ferber, Sarah, Methods of transdifferentiation and methods of use thereof.
  465. Pellman, David, Methods of treating a meiotic kinesin associated disease.
  466. Pellman, David, Methods of treating a meiotic kinesin associated disease.
  467. Pellman, David, Methods of treating a meiotic kinesin-associated disease.
  468. Rothenberg, Marc E.; Caldwell, Julie, Methods of treating allergic inflammatory conditions by administering an anti-cadherin-like 26-based therapeutic.
  469. Muller, Sylviane; Zimmer, Robert H.; Briand, Jean-Paul, Methods of treating chronic inflammatory diseases.
  470. Bryant, Martin L.; Sommadossi, Jean-Pierre, Methods of treating hepatitis delta virus infection with β-L-2′-deoxy-nucleosides.
  471. Gjorstrup, Per, Methods of treating ototoxicity.
  472. Gjorstrup, Per, Methods of treating ototoxicity.
  473. Hajjar,Roger J.; Lompr,Anne Marie; Lipskaia,Larissa; Del Monte,Federica, Methods of treating restenosis.
  474. Williams, Dustin; Looper, Ryan; Jeyapalina, Sujeevini; Haussener, Travis; Sebahar, Paul R.; Reddy, Hari Kanna, Methods of use comprising a biocidal polyamine.
  475. Williams, Dustin; Looper, Ryan; Jeyapalina, Sujeevini; Haussener, Travis; Sebahar, Paul R.; Reddy, Hari Kanna, Methods of use for compositions comprising a biocidal polyamine.
  476. Hom,Roy; Mamo,Shumeye S.; Tung,Jay; Gailunas,Andrea; John,Varghese; Fang,Lawrence Y., Methods to treat alzheimer's disease.
  477. Kong, Xianqi; Atfani, Mohamed; Bachand, Benoit; Bouzide, Abderrahim; Ciblat, Stephane; Levesque, Sophie; Migneault, David; Valade, Isabelle; Wu, Xinfu; Delorme, Daniel, Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid.
  478. Kong, Xianqi; Atfani, Mohamed; Bachand, Benoit; Bouzide, Abderrahim; Ciblat, Stephane; Levesque, Sophie; Migneault, David; Valade, Isabelle; Wu, Xinfu; Delorme, Daniel, Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid.
  479. Wu, Libo; Zhang, Jian, Methysergide derivatives.
  480. Marasco, Wayne A.; Tang, Xiangchun, Middle east respiratory syndrome coronavirus neutralizing antibodies and methods of use thereof.
  481. Storer, Richard; Gosselin, Gilles; Sommadossi, Jean Pierre; LaColla, Paola, Modified 2' and 3'-nucleoside prodrugs for treating infections.
  482. LaColla,Paola; Storer,Richard; Gosselin,Gilles; Sommadossi,Jean Pierre, Modified 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections.
  483. LaColla, Paola; Storer, Richard; Gosselin, Gilles; Sommadossi, Jean Pierre, Modified 2' and 3'-nucleoside prodrugs for treating infections.
  484. LaColla, Paola; Storer, Richard; Gosselin, Gilles; Sommadossi, Jean Pierre, Modified 2' and 3'-nucleoside prodrugs for treating infections.
  485. LaColla,Paola; Storer,Richard; Gosselin,Gilles; Sommadossi,Jean Pierre, Modified 2' and 3'-nucleoside prodrugs for treatinginfections.
  486. LaColla,Paola; Storer,Richard; Gosselin,Gilles; Sommadossi,Jean Pierre, Modified 2' and 3'-nucleoside prodrugs for treatinginfections.
  487. Corcoran,Christopher John; Flannery,Carl R.; Zeng,Weilan; Racie,Lisa A.; McDonagh,Thomas; Freeman,Bethany A.; Georgiadis,Katy E.; LaVallie,Edward R., Modified ADAMTS4 molecules and method of use thereof.
  488. Madison, Edwin L.; Nguyen, Jack; Ruggles, Sandra Waugh; Thanos, Christopher, Modified MT-SP1 proteases that inhibit complement activation.
  489. Stagliano, Nancy E.; West, James W.; Kamath, Kathryn; Bessette, Paul H.; Gluck, Fred; Sagert, Jason; Daugherty, Patrick, Modified antibody compositions, methods of making and using thereof.
  490. Stagliano, Nancy E.; West, James William; Kamath, Kathryn; Bessette, Paul Henry; Gluck, Fred; Sagert, Jason Gary; Daugherty, Patrick, Modified antibody containing the cleavable peptide with the amino acid sequence TGRGPSWV.
  491. Oyhenart, Jorge; Gallet, Xavier; Borrelly, Gilles; Guyon, Thierry; Vega, Manuel; Drittanti, Lila, Modified coagulation factor IX polypeptides and use thereof for treatment.
  492. Madison, Edwin L.; Thanos, Christopher; Blouse, Grant Ellsworth, Modified factor IX polypeptides and uses thereof.
  493. Madison, Edwin L.; Thanos, Christopher; Blouse, Grant Ellsworth, Modified factor IX polypeptides and uses thereof.
  494. Madison, Edwin L.; Thanos, Christopher, Modified factor X polypeptides and uses thereof.
  495. Madison, Edwin L.; Thanos, Christopher, Modified factor X polypeptides and uses thereof.
  496. Guyon, Thierry; Borrelly, Gilles; Drittanti, Lila; Vega, Manuel, Modified growth hormone.
  497. Guyon, Thierry; Borrelly, Gilles; Drittanti, Lila; Vega, Manuel, Modified growth hormones.
  498. Guyon, Thierry; Borrelly, Gilles; Drittanti, Lila; Vega, Manuel, Modified growth hormones that exhibit increased protease resistance and pharmaceutical compositions thereof.
  499. Muller, Sylviane; Briand, Jean-Paul; Zimmer, Robert H., Modified peptides and their use for treating autoimmune diseases.
  500. Fan, Daping, Modulation of macrophage phenotype by emodin.
  501. Lindquist, Per; Mercer, Alex; Rönnholm, Harriet; Wikström, Lilian, Modulation of neural stem cells and neural progenitor cells.
  502. Lindquist, Per; Mercer, Alex; Rönnholm, Harriet; Wikström, Lilian, Modulation of neural stem cells and neural progenitor cells.
  503. Fairlie, David Paul; Liu, Ligong; Yau, Mei Kwan; Suen, Jacky Yung; Reid, Robert, Modulations of protease activated receptors.
  504. Fairlie, David Paul; Liu, Ligong; Yau, Mei Kwan; Suen, Jacky Yung; Reid, Robert, Modulations of protease activated receptors.
  505. Wang, Yue; Xu, Xiao-Li; Lee, Raymond Teck Ho, Modulators of Candida hyphal morphogenesis and uses thereof.
  506. Wang, Yue; Xu, Xiao-Li; Lee, Raymond Teck Ho, Modulators of Candida hyphal morphogenesis and uses thereof.
  507. Wang, Yue; Xu, Xiao-Li; Lee, Teck Ho Raymond, Modulators of Candida hyphal morphogenesis and uses thereof.
  508. Fairlie, David Paul; Liu, Ligong; Yau, Mei Kwan; Suen, Jacky Yung; Reid, Robert, Modulators of protease activated receptors.
  509. Fairlie, David; Liu, Ligong; Yau, Mei-Kwan; Suen, Jacky Yung; Reid, Robert; Lohman, Rink-Jan; Iyer, Abishek Venkatasubramanian; Lim, Junxian; Brown, Lindsay Charles, Modulators of protease activated receptors.
  510. Kahne, Daniel Evan; Kahne, Suzanne Walker; Tsukamoto, Hirokazu, Moenomycin analogs, methods of synthesis, and uses thereof.
  511. Kahne, Daniel; Kahne, Suzanne Walker; Adachi, Masaatsu; Doud, Emma; Fuse, Shinichiro; Lin, Xiaonan; Zhang, Yi; Tsukamoto, Hirokazu; Ostash, Bohdan, Moenomycin analogs, methods of synthesis, and uses thereof.
  512. Walker, Suzanne; Omelyanovich Ostash, Bohdan, Moenomycin biosynthesis-related compositions and methods of use thereof.
  513. Sahin, Ugur; Tureci, Ozlem; Usener, Dirk; Fritz, Stefan; Uherek, Christoph; Brandenburg, Gunda; Geppert, Harald-Gerhard; Schroder, Anja Kristina; Thiel, Phillippe, Monoclonal antibodies against claudin-18 for treatment of cancer.
  514. Sahin, Ugur; Türeci, Özlem; Usener, Dirk; Fritz, Stefan; Uherek, Christoph; Brandenburg, Gunda; Geppert, Harald-Gerhard; Schröder, Anja Kristina; Thiel, Phillippe, Monoclonal antibodies against claudin-18 for treatment of cancer.
  515. Sahin, Ugur; Türeci, Özlem; Usener, Dirk; Fritz, Stefan; Uherek, Christoph; Brandenburg, Gunda; Geppert, Harald-Gerhard; Schröder, Anja Kristina; Thiel, Phillippe, Monoclonal antibodies against claudin-18 for treatment of cancer.
  516. Sahin, Ugur; Türeci, Özlem; Usener, Dirk; Fritz, Stefan; Uherek, Christoph; Brandenburg, Gunda; Geppert, Harald-Gerhard; Schröder, Anja Kristina; Thiel, Phillippe, Monoclonal antibodies against claudin-18 for treatment of cancer.
  517. Sahin, Ugur; Türeci, Özlem; Usener, Dirk; Fritz, Stefan; Uherek, Christoph; Brandenburg, Gunda; Geppert, Harald-Gerhard; Schröder, Anja Kristina; Thiel, Phillippe, Monoclonal antibodies against claudin-18 for treatment of cancer.
  518. Sahin, Ugar; Koslowski, Michael; Tureci, Ozlem, Monoclonal antibodies for treatment of cancer.
  519. Sahin, Ugur; Koslowski, Michael; Tureci, Ozlem, Monoclonal antibodies for treatment of cancer.
  520. Sahin, Ugur; Koslowski, Michael; Türeci, Özlem, Monoclonal antibodies for treatment of cancer.
  521. Sahin, Ugur; Koslowski, Michael; Türeci, Özlem, Monoclonal antibodies for treatment of cancer.
  522. Sahin, Ugur; Tureci, Ozlem; Koslowski, Michael; Mitnacht-Kraus, Rita, Monoclonal antibodies for treatment of cancer.
  523. Sahin, Ugur; Tureci, Ozlem; Koslowski, Michael; Mitnachtkraus, Rita, Monoclonal antibodies for treatment of cancer.
  524. Pandey, Ravindra K.; Goswami, Lalit; Spernyak, Joseph; Kanter, Peter; Mazurchuk, Richard, Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents.
  525. Boppart, Stephen A.; Wei, Alexander, Multi-functional plasmon-resonant contrast agents for optical coherence tomography.
  526. Barr, Philip J.; Gibson, Helen L.; Pemberton, Philip A., Multifunctional protease inhibitors and their use in treatment of disease.
  527. Barr,Philip J.; Gibson,Helen L.; Pemberton,Philip A., Multifunctional protease inhibitors and their use in treatment of disease.
  528. Fang, Fang; Luo, Guang-Xiang; Kohlstaedt, Lori Allison; Charles, Catherine Helen, Multimeric proteins and methods of making and using same.
  529. John,Varghese; Maillard,Michel; Jagodzinska,Barbara; Beck,James; Gailunas,Andrea; Freskos,John; Mickelson,John; Samala,Lakshman; Sealy,Jennifer; TenBrink,Ruth; Fang,Lawrence; Hom,Roy, N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives.
  530. John, Varghese; Maillard, Michel; Jagodzinska, Barbara; Beck, James; Gailunas, Andrea; Freskos, John; Mickelson, John; Samala, Lakshman; Sealey, Jennifer; Tenbrink, Ruth; Fang, Larry; Hom, Roy, N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives.
  531. Chan Ming Fai ; Wu Chengde ; Raju Bore Gowda ; Kogan Timothy ; Kois Adam ; Verner Erik Joel ; Castillo Rosario Silvestre ; Yalamoori Venkatachalapathi ; Balaji Vitukudi Narayanaiyengar, N-Alkyl, N-Alkenyl, N-Alkynyl, N-Aryl and N-fused bicyclo or tricyclo thienyl-, furyl-,and Pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin.
  532. Otto,Michael J.; Shi,Junxing; Watanabe,Kyoichi A., N-acylcytosine nucleosides for treatment of viral infections.
  533. Otto, Michael J.; Shi, Junxing; Watanabe, Kyoichi A., N4-acylcytosine nucleosides for treatment of viral infections.
  534. Watanabe, Kyoichi A.; Shi, Junxing; Otto, Michael J., N4-acylcytosine-1,3-dioxolane nucleosides for treatment of viral infections.
  535. Watanabe, Kyoichi A.; Shi, Junxing; Otto, Michael J., N4-acylcytosine-1,3-dioxolane nucleosides for treatment of viral infections.
  536. Pettit, George R.; Melody, Noeleen, Narcistatin prodrugs.
  537. Pettit,George R.; Melody,Noeleen, Narcistatin prodrugs.
  538. Shen T. Y. (Charlottesville VA) Goldstein David (Pittsburgh PA) Gingrich Diane M. (Tempe AZ), Neolignan derivatives as platelet activating factor receptor antagonists and 5-lipoxygenase inhibitors.
  539. Cook, Robert O.; Zhang, Jian; Armer, Thomas A., Neuromodulatory compounds.
  540. Horowitz, Lawrence; Bhatt, Ramesh; Kashyap, Arun, Neutralizing molecules to influenza viruses.
  541. Boppart, Stephen A.; Marks, Daniel L., Nonlinear interferometric vibrational imaging.
  542. Madison,Edwin L.; Yeh,Jiunn Chern, Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon.
  543. Madison,Edwin L.; Ong,Edgar O., Nucleic acid molecules encoding a transmembrane serine protease 7, the encoded polypeptides and methods based thereon.
  544. Madison,Edwin L.; Ong,Edgar O., Nucleic acid molecules encoding a transmembrane serine protease 9, the encoded polypeptides and methods based thereon.
  545. Madison,Edwin L.; Yeh,Jiunn Chern, Nucleic acid molecules encoding serine protease CVSP14, the encoded polypeptides and methods based thereon.
  546. Madison, Edwin L.; Ong, Edgar O.; Yeh, Jiunn-Chern, Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon.
  547. Madison, Edwin L.; Ong, Edgar O.; Yeh, Jiunn-Chern, Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon.
  548. Oeth, Paul Andrew; Mahboubi, Payam; Lee, Min Seob, Nucleic acid-based tests for prenatal gender determination.
  549. Valge-Archer, Viia; Williams, Andrew James; Young, Deborah A.; Whitters, Matthew J.; Collins, Mary; Witek, Joann, Nucleic acids coding for antibodies against human IL-21 receptor and uses therefor.
  550. Madison,Edwin L.; Ong,Edgar O., Nucleic acids encoding endotheliases, endotheliases and uses thereof.
  551. Qiu, Xiao-Qing, Nucleic acids molecule encoding the polypeptide for treating virus-induced cancer.
  552. Huang, Raven H.; Liu, Xianjun, Nucleoside analog inhibitors of reverse transcriptase.
  553. Schinazi Raymond F. ; Fulcrand-El Kattan Geraldine ; Lesnikowski Zbigniew Jan, Nucleosides and oligonucleotides containing boron clusters.
  554. Schinazi, Raymond F.; Fulcrand-El Kattan, Geraldine; Lesnikowski, Zbigniew Jan, Nucleosides and oligonucleotides containing boron clusters.
  555. Hostetler, Karl Y.; Beadle, James R.; Valiaeva, Nadejda, Nucleotide analogs.
  556. Hostetler, Karl Y.; Beadle, James R.; Valiaeva, Nadejda, Nucleotide analogs.
  557. Khvorova, Anastasia; Aronin, Neil; Alterman, Julia, Oligonucleotide compounds for targeting huntingtin mRNA.
  558. Khvorova, Anastasia; Moore, Melissa; Turanov, Anton A.; Karumanchi, Ananth, Oligonucleotide compounds for treatment of preeclampsia and other angiogenic disorders.
  559. Boppart,Stephen A.; Marks,Daniel L.; Suslick,Kenneth S.; Toublan,Farah Jean Jacques, Optical contrast agents for optically modifying incident radiation.
  560. Okada Junichi,JPX ; Cohen Smadar,ILX ; Langer Robert S., Oral delivery of vaccines using polymerized liposomes.
  561. Bettencourt, Brian Richard; Bumcrot, David Anton; Huesken, Dieter; Kuchimanchi, Satyanarayana; Milstein, Stuart; Schlabach, Jr., Michael Ray; Stegmeier, Frank Peter; Warmuth, Markus; Weiler, Jan, Organic compositions to treat beta-catenin-related diseases.
  562. Karsenty, Gerard; Oury, Franck, Osteocalcin as a treatment for cognitive disorders.
  563. Karsenty, Gerard; Ducy, Patricia F., Osteocalcin as a treatment for male reproductive disorders.
  564. Guibourt, Nathalie; Munoz, Alberto Ortega; Laria, Julio Castro-Palomino, Oxidase inhibitors and their use.
  565. John,Varghese; Maillard,Michel; Jagodzinska,Barbara; Aquino,Jose; Probst,Gary; Tung,Jay, Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors.
  566. Minnich,Anne; Kuntzweiler,Theresa; Eishingdrelo,Haifeng; Angelastro,Michael; Henke,Stephan, Oxydecahydronaphthalene modulators of HM74.
  567. Dong, Qing; Pierre, Fabrice; Wang, Jianqiang, P-38 inhibitors.
  568. McMinn, Dustin; Johnson, Henry; Bowers, Simeon; Moebius, David C., Peptide epoxyketone immunoproteasome inhibitors.
  569. Lazarus, Robert A.; Zhang, Yingnan; Wang, Weiru, Peptide inhibitors of BACE1.
  570. Lazarus, Robert A.; Zhang, Yingnan; Wang, Weiru, Peptide inhibitors of BACE1.
  571. Popescu Mircea C. ; Weiner Alan L. ; Recine Marie S. ; Janoff Andrew S. ; Estis Leonard ; Keyes Lynn D. ; Alving Carl R., Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use.
  572. Cutler Jim E. ; Glee Pati M., Peptides which mimic candida carbohydrate epitopes and their use in a vaccine.
  573. Jim E. Cutler ; Pati M. Glee ; Bruce L. Granger, Peptides which mimic candida carbohydrate epitopes and their use in a vaccine.
  574. Jim E. Cutler ; Yongmoon Han, Peptides which mimic candida carbohydrate epitopes and their use in a vaccine.
  575. Fidler Isaiah J. (Kingwood TX), Pharmaceutical administration systems containing a mixture of immunomodulators.
  576. Mehrling, Thomas Jorg, Pharmaceutical combination comprising a class III receptor tyrosine kinase inhibitor and the alkylating histone-deacetylase inhibitor fusion molecule EDO-S101 together with its use in the treatment of cancer.
  577. Chen, Yu; Yang, Lan; Feng, Feiyu; Ge, Qiufu; Guo, Dianwu; Chen, Yi, Pharmaceutical compositions.
  578. Guibourt, Nathalie; Ortega Munoz, Alberto; Castro-Palomino Laria, Julio, Phenylcyclopropylamine derivatives and their medical use.
  579. Szarek Walter A.,CAX ; Kong Xianqi,CAX, Phosphono-carboxylate compounds for treating amyloidosis.
  580. Walter A. Szarek CA; Xianqi Kong CA; Gregory R. J. Thatcher CA; Boris Gorine CA, Phosphono-carboxylate compounds for treating amyloidosis.
  581. Gygi, Steven P.; Villen, Judit; Beausoleil, Sean, Phosphopeptide compositions and anti-phosphopeptide antibody compositions and methods of detecting phosphorylated peptides.
  582. Chan Ming Fai ; Verner Erik Joel, Phosphoramidates, phosphinic amides and related compounds and the use thereof to modulate the activity of endothelin.
  583. Ming Fai Chan ; Erik Joel Verner, Phosphoramidates, phosphinic amides and related compounds and the use thereof to modulate the activity of endothelin.
  584. Lu, Xin; Agasti, Sarit S.; DePinho, Ronald A.; Weissleder, Ralph, Photoactivatable caged tamoxifen and tamoxifen derivative molecules and methods of use thereof.
  585. Mazitschek, Ralph; Ghosh, Balaram; Hendricks, James Adam; Reis, Surya; Haggarty, Stephen John, Photoswitchable HDAC inhibitors.
  586. Zaveri, Nurulain; Meyer, Michael, Piperdinyl nociceptin receptor compounds.
  587. Madison, Edwin L.; Brunck, Terence K.; Semple, Joseph Edward; Lim-Wilby, Marguerita; Pryor, Kent E., Plasminogen activator inhibitor antagonists.
  588. Madison, Edwin L.; Brunck, Terence K.; Semple, Joseph Edward; Lim-Wilby, Marguerita; Pryor, Kent E.; Lewis, II, Ronald D.; Duncan, David F.; Lawrence, C. Maxwell, Plasminogen activator inhibitor antagonists.
  589. Emanuele, R. Martin; Balasubramanian, Mannarsamy; Smith, Stewart V., Poloxamer composition free of long circulating material and methods for production and uses thereof.
  590. Emanuele, R. Martin; Vetticaden, Santosh; Keran, Patrick, Poloxamer therapy for heart failure.
  591. Baden,Daniel G.; Abraham,William M.; Bourdelais,Andrea J., Polyether brevetoxin derivatives as a treatment for cystic fibrosis, mucociliary dysfunction, and pulmonary diseases.
  592. Chen Hongming ; Langer Robert S., Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery.
  593. Hongming Chen ; Robert S. Langer, Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery.
  594. Hu, Yuerong; Law, Devalina; Phares, Kenneth R., Polymorphic and other crystalline forms cis-FTC.
  595. Hu, Yuerong; Phares, Kenneth R.; Law, Devalina, Polymorphic and other crystalline forms of cis-FTC.
  596. Hu, Yuerong; Phares, Kenneth R.; Law, Devalina, Polymorphic and other crystalline forms of cis-FTC.
  597. Miller, Thomas A.; Richon, Victoria M., Polymorphs of suberoylanilide hydroxamic acid.
  598. Miller, Thomas A.; Richon, Victoria M., Polymorphs of suberoylanilide hydroxamic acid.
  599. Clark, Richard A., Polypeptides and methods of use.
  600. Cohen-Dayag, Anat; Beiman, Merav; Dassa, Liat; Bubis, Marina; Greenwald, Shirley Sameach-; Landesman-Milo, Dalit; Koifman, Cynthia; Levy, Ofer; Nemzer, Sergey; Pergam, Tania; Kinar, Yaron; Levine, Zurit; Rosenberg, Avi; Rotman, Galit; Montia, Eve; Novik, Amit; Toporik, Amir; Walach, Shira, Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics.
  601. Levine, Zurit; Pergam, Tania; Landesman-Milo, Dalit; Cohen-Dayag, Anat; Toporik, Amir; Kinar, Yaron; Nemzer, Sergey; Rosenberg, Avi; Rotman, Galit; Novik, Amit; Koifman, Cynthia; Beiman, Merav; Dassa, Liat; Walach, Shira; Montia, Eve; Sameach-Greenwald, Shirley; Levy, Ofer; Bubis, Marina, Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics.
  602. Levine, Zurit; Toporik, Amir; Novik, Amit; Cohen-Dayag, Anat; Rosenberg, Avi; Koifman, Cynthia; Landesman-Milo, Dalit; Montia, Eve; Rotman, Galit; Dassa, Liat; Bubis, Marina; Beiman, Merav; Levy, Ofer; Nemzer, Sergey; Walach, Shira; Greenwald, Shirley Sameach-; Pergam, Tania; Kinar, Yaron, Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics.
  603. Toporik, Amir; Novik, Amit; Cohen-Dayag, Anat; Rosenberg, Avi Yeshah; Koifman, Cynthia; Landesman-Milo, Dalit; Montia, Eve; Rotman, Galit; Dassa, Liat; Bubis, Marina; Beiman, Merav; Levi, Ofer; Nemzer, Sergey; Pergam, Tania; Kinar, Yaron; Greenwald, Shirley Sameach-; Levine, Zurit; Walach, Shira, Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics.
  604. Toporik, Amir; Novik, Amit; Cohen-Dayag, Anat; Rosenberg, Avi Yeshah; Koifman, Cynthia; Landesman-Milo, Dalit; Montia, Eve; Rotman, Galit; Dassa, Liat; Bubis, Marina; Beiman, Merav; Levy, Ofer; Nemzer, Sergey; Pergam, Tania; Kinar, Yaron; Sameach-Greenwald, Shirley; Levine, Zurit; Walach, Shira, Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics.
  605. Toporik, Amir; Rosenberg, Avi Yeshah; Rotman, Galit; Hecht, Iris; Levine, Zurit, Polypeptides and uses thereof for treatment of autoimmune disorders and infection.
  606. Cesar Castro Palomino Laria, Julio; Muñoz, Alberto Ortega; Guibourt, Nathalie; Baker, Jonathan Alleman, Potent selective LSD1 inhibitors and dual LSD1/MAO-B inhibitors for antiviral use.
  607. Popescu Mircea C. ; Weiner Alan L. ; Recine Marie S. ; Janoff Andrew S. ; Estis Leonard ; Keyes Lynn D. ; Alving Carl R., Potentiation of immune responses with liposomal adjuvants.
  608. Myhill,Paul R.; Driscoll,William J., Preparation of compositions to alleviate inflammation and oxidative stress in a mammal.
  609. Mayes, Benjamin Alexander; Moussa, Adel, Process for preparing a synthetic intermediate for preparation of branched nucleosides.
  610. Storer, Richard; Moussa, Adel M.; Chaudhuri, Narayan; Waligora, Frank, Process for the production of 2-C-methyl-D-ribonolactone.
  611. Ehrich, Mathias; Nygren, Anders Olof Herman, Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses.
  612. Ehrich, Mathias; Nygren, Anders Olof Herman; Jensen, Taylor Jacob, Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses.
  613. Ehrich, Mathias; Mistro, Guy Del; Deciu, Cosmin; Chen, Yong Qing; McCullough, Ron Michael; Tim, Roger Chan, Processes and kits for identifying aneuploidy.
  614. Drapeau,Denis; Luan,Yen Tung; Mercer,James R.; Wang,Wenge; Lasko,Daniel R., Production of TNFR-Ig.
  615. Drapeau,Denis; Luan,Yen Tung; Mercer,James R.; Wang,Wenge; Lasko,Daniel R., Production of anti-abeta.
  616. Drapeau,Denis; Luan,Yen Tung; Mercer,James R.; Wang,Wenge; Lasko,Daniel R., Production of polypeptides.
  617. Bearss, David J.; Siddiqui-Jain, Adam; Whatcott, Clifford J.; Peterson, Peter W.; Warner, Steven L.; Mouritsen, Lars, Profiling peptides and methods for sensitivity profiling.
  618. Sands, Roger Warren; Barros E Silva, Eduardo Alexandre; Kawai, Toshihisa; Mooney, David J., Programming of cells for tolerogenic therapies.
  619. Sands, Roger Warren; Barros e Silva, Eduardo Alexandre; Kawai, Toshihisa; Mooney, David J., Programming of cells for tolerogenic therapies.
  620. Gantier, Rene; Vega, Manuel; Drittanti, Lila; Guyon, Thierry, Protease resistant interferon beta mutants.
  621. Gantier, Rene; Vega, Manuel; Drittanti, Lila; Guyon, Thierry, Protease resistant modified IFN beta polypeptides and their use in treating diseases.
  622. Gantier, Rene; Vega, Manuel; Drittanti, Lila; Guyon, Thierry, Protease resistant modified erythropoietin polypeptides.
  623. Gantier, Rene; Vega, Manuel; Drittanti, Lila; Guyon, Thierry, Protease resistant modified interferon alpha polypeptides.
  624. Gantier, Rene; Vega, Manuel; Drittanti, Lila; Guyon, Thierry, Protease resistant modified interferon-beta polypeptides.
  625. Mezes,Peter; Rastelli,Luca; Herrmann,John; MacDougall,John; Zhong,Haihong; Casman,Stacie; Boldog,Ferenc; Shimkets,Richard; Gorman,Linda; Eisen,Andrew; Spaderna,Steven; Vernet,Corine; Berghs,Constance, Proteins and nucleic acids encoding same.
  626. Rastelli, Luca; Herrmann, John L.; MacDougall, John R.; Zhong, Haihong, Proteins and nucleic acids encoding same.
  627. Gillies, Stephen D.; Way, Jeffrey; Lo, Kin-Ming, Proteins comprising an IgG2 domain.
  628. Crews, Craig; Toure, Momar; Ko, Eunhwa; Jaime-Figueroa, Saul, Proteolysis targeting chimera compounds and methods of preparing and using same.
  629. Krishnamurthy, Vijay M.; Estroff, Lara A.; Semetey, Vincent; Thomas, Samuel W.; Kaufman, George K.; Bilgicer, Zihni Basar; Whitesides, George M., Purification of a bivalently active antibody using a non-chromatographic method.
  630. Ludwig, Janos; Goldeck, Marion; Sproat, Brian, Purification of triphosphorylated oligonucleotides using capture tags.
  631. Ludwig, Janos; Goldeck, Marion; Sproat, Brian, Purification of triphosphorylated oligonucleotides using capture tags.
  632. Reed, David P.; Barnes, Neil R.; Kane, John C.; Lee, Christopher A.; Chen, Jian-Xie; Redmon, Martin P., Purified pyrroloquinolinyl-pyrrolidine-2,5-dione compositions and methods for preparing and using same.
  633. Reed, David P.; Barnes, Neil R.; Kane, John C.; Lee, Christopher A.; Chen, Jian-Xie; Redmon, Martin P., Purified pyrroloquinolinyl-pyrrolidine-2,5-dione compositions and methods for preparing and using same.
  634. Reed, David P.; Barnes, Neil R.; Kane, John C.; Lee, Christopher A.; Chen, Jian-Xie; Redmon, Martin P., Purified pyrroloquinolinyl-pyrrolidine-2,5-dione compositions and methods for preparing and using same.
  635. Storer, Richard; Gosselin, Gilles; Dukhan, David; Leroy, Frederic, Purine nucleoside analogues for treating flaviviridae including hepatitis C.
  636. Storer, Richard; Gosselin, Gilles; Dukhan, David; Leroy, Frederic, Purine nucleoside analogues for treating flaviviridae including hepatitis C.
  637. Daniels, David J.; Parney, Ian F.; Peterson, Timothy E., Pyrazole derivatives as inhibitors of STAT3.
  638. Daniels, David J.; Parney, Ian F.; Peterson, Timothy E., Pyrazole derivatives as inhibitors of STAT3.
  639. Sattler, Michael; Popowicz, Grzegorz; Dawidowski, Maciej; Emmanouilidis, Leonidas; Erdmann, Ralf; Schliebs, Wolfgang; Kalel, Vishal, Pyrazolopyridine derivatives and their use in therapy.
  640. Sattler, Michael; Popowicz, Grzegorz; Dawidowski, Maciej; Emmanouilidis, Leonidas; Erdmann, Ralf; Schliebs, Wolfgang; Kalel, Vishal, Pyrazolopyridine derivatives and their use in therapy.
  641. Wang, Jianqiang; Ali, Syed M.; Kelleher, Eugene; Liu, Yanbin; Hill, Jason; Ashwell, Mark A., Pyrrolidinone, pyrrolidine-2,5-dione, pyrrolidine and thiosuccinimide derivatives, compositions and methods for treatment of cancer.
  642. Ashwell, Mark A.; Kizer, Darin; Murai, Takahiro; Nakai, Daisuke; Yasukochi, Takanori, Pyrroloquinolinyl-pyrrolidine-2,5-dione compositions and methods for preparing and using same.
  643. Yamakose, Hiroshi; Kato, Takafumi, Pyrroloquinolinyl-pyrrolidine-2,5-dione formulations and methods for preparing and using same.
  644. Nygren, Anders, Quantification of a minority nucleic acid species.
  645. Nygren, Anders, Quantification of a minority nucleic acid species.
  646. Nygren, Anders, Quantification of a minority nucleic acid species.
  647. Liu, Jifeng; Ali, Syed M.; Ashwell, Mark A.; Ye, Ping; Guan, Yousheng; Ng, Shi-Chung; Palma, Rocio; Yohannes, Dan, Quinazolinone compounds and methods of use thereof.
  648. Goldeck, Marion; Van Den Boorn, Jasper; Ludwig, János; Schuberth-Wagner, Christine, RIG-I ligands and methods for producing them.
  649. Goldeck, Marion; Van Den Boorn, Jasper; Ludwig, János; Schuberth-Wagner, Christine, RIG-I ligands and methods for producing them.
  650. Gantier, Rene; Vega, Manuel; Drittanti, Lila; Guyon, Thierry, Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules.
  651. Colonna, Marco; Bouchon, Axel; Salbo, Rune; Wiberg, Charlotte; Stennicke, Vibeke W.; Henriksen, Anette; Andersen, Mette D., Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof.
  652. Colonna, Marco; Bouchon, Axel, Receptor trem (triggering receptor expressed on myeloid cells) and uses thereof.
  653. Gillies, Stephen D.; Lo, Kin-Ming; Qian, Susan X., Recombinant tumor specific antibody and use thereof.
  654. Gillies, Stephen D.; Lo, Kin-Ming; Qian, Susan Xiuqi, Recombinant tumor specific antibody and use thereof.
  655. Gillies,Stephen D.; Lo,Kin Ming; Qian,Susan Xiuqi, Recombinant tumor specific antibody and use thereof.
  656. Gillies, Stephen D.; Way, Jeffrey; Hamilton, Anita A., Reducing the immunogenicity of fusion proteins.
  657. Gillies, Stephen D.; Way, Jeffrey; Hamilton, Anita A., Reducing the immunogenicity of fusion proteins.
  658. Gillies, Stephen D.; Way, Jeffrey; Hamilton, Anita A., Reducing the immunogenicity of fusion proteins.
  659. Gillies,Stephen D.; Hamilton,Anita A., Reducing the immunogenicity of fusion proteins.
  660. De Groot, Anne; Martin, William; Rivera, Daniel S., Regulatory T cell epitopes, compositions and uses thereof.
  661. De Groot, Anne; Martin, William; Rivera, Daniel S., Regulatory T cell epitopes, compositions and uses thereof.
  662. Meng, Charles Q., Salt forms of poorly soluble probucol esters and ethers.
  663. Meng,Charles Q., Salt forms of poorly soluble probucol esters and ethers.
  664. Qi, Xiaoyang, Saposin C-DOPS: a novel anti-tumor agent.
  665. Mooney, David J.; Ali, Omar Abdel-Rahman, Scaffolds for cell collection or elimination.
  666. Mooney, David J.; Ali, Omar Abdel-Rahman; Barros E Silva, Eduardo Alexandre; Kong, Hyun Joon; Hill, Jr., Elliot Earl; Boontheekul, Tanyarut, Scaffolds for cell transplantation.
  667. Mooney, David J.; Ali, Omar Abdel-Rahman; Barros E Silva, Eduardo Alexandre; Kong, Hyun Joon; Hill, Jr., Elliot Earl; Boontheekul, Tanyarut, Scaffolds for cell transplantation.
  668. Mooney, David J.; Ali, Omar Abdel-Rahman; Barros E Silva, Eduardo Alexandre; Kong, Hyun Joon; Hill, Jr., Elliot Earl; Boontheekul, Tanyarut, Scaffolds for cell transplantation.
  669. Mooney, David J.; Ali, Omar Abdel-Rahman; Barros E Silva, Eduardo Alexandre; Kong, Hyun Joon; Hill, Jr., Elliot Earl; Boontheekul, Tanyarut, Scaffolds for cell transplantation.
  670. Zhi, Lin, Selective androgen receptor modulators (SARMS) and uses thereof.
  671. Zhi, Lin, Selective androgen receptor modulators (SARMs) and uses thereof.
  672. Zhi, Lin, Selective androgen receptor modulators (SARMs) and uses thereof.
  673. Zhi, Lin, Selective androgen receptor modulators (SARMs) and uses thereof.
  674. Zhi, Lin, Selective androgen receptor modulators (SARMs) and uses thereof.
  675. Shreder, Kevin; Hu, Yi; Fraser, Allister; Kohno, Yasushi; Kojima, Akihiko; Ishiyama, Junichi, Serine hydrolase inhibitors.
  676. Eckelman, Brendan; Timmer, John; Deveraux, Quinn, Serpin fusion polypeptides and methods of purification thereof.
  677. Eckelman, Brendan; Timmer, John; Nguy, Peter L.; Guenther, Grant B.; Deveraux, Quinn, Serpin fusion polypeptides and methods of use thereof.
  678. Henriksen, Anette; Kjærgaard, Kristian; Stennicke, Vibeke Westphal; Wiberg, Charlotte, Site directed mutagenesis of TREM-1 antibodies for decreasing viscosity.
  679. Kazantsev, Aleksey G.; Thompson, Leslie M.; Abagyan, Ruben; Casale, Malcolm, Small molecule activators of NRF2 pathway.
  680. Pang, Yuan-Ping; Park, Jewn Giew; Tang, Jing; Millard, Charles B.; Schmidt, James J., Small-molecule botulinum toxin inhibitors.
  681. Pang, Yuan-Ping; Park, Jewn Giew; Wang, Shaohua; Vummenthala, Anuradha; Mishra, Rajesh K; Davis, Jon; Millard, Charles B.; Schmidt, James J., Small-molecule botulinum toxin inhibitors.
  682. Finberg, Robert W.; Asher, Damon R., Snares for pathogenic or infectious agents and uses related thereto.
  683. Fernandez, Paul F.; Ferretti, Antonio C.; Kothare, Mohit A.; Li, Ying; Man, Hon-Wah; Zhang, Weihong, Solid forms of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide, and their pharmaceutical compositions and uses.
  684. Benito Munoz ; Chixu Chen, Solid phase synthesis of heterocycles.
  685. Maihle, Nita J.; Lee, Hakjoo, Soluble ErbB3 and treatment of cancer.
  686. Maihle, Nita J.; Lee, Hakjoo, Soluble ErbB3 methods of detection and antibodies.
  687. Bookbinder, Louis H.; Kundu, Anirban; Frost, Gregory I., Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases.
  688. Bookbinder, Louis H.; Kundu, Anirban; Frost, Gregory I., Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases.
  689. Bookbinder, Louis H.; Kundu, Anirban; Frost, Gregory I., Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases.
  690. Bookbinder, Louis H.; Kundu, Anirban; Frost, Gregory I., Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases.
  691. Bookbinder, Louis H.; Kundu, Anirban; Frost, Gregory I., Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases.
  692. Bookbinder, Louis H.; Kundu, Anirban; Frost, Gregory I., Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases.
  693. Bookbinder, Louis H.; Kundu, Anirban; Frost, Gregory I., Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases.
  694. Bookbinder, Louis; Kundu, Anirban; Frost, Gregory I., Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases.
  695. Bookbinder, Louis H.; Kundu, Anirban; Frost, Gregory I., Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof.
  696. Bookbinder, Louis H.; Kundu, Anirban; Frost, Gregory I., Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof.
  697. Bookbinder, Louis H.; Kundu, Anirban; Frost, Gregory I., Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof.
  698. Bookbinder, Louis H.; Kundu, Anirban; Frost, Gregory I., Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof.
  699. Bookbinder, Louis H.; Kundu, Anirbau; Frost, Gregory I., Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof.
  700. Bookbinder, Louis; Kundu, Anirban; Frost, Gregory I., Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof.
  701. Grandis, Jennifer R.; Johnson, Daniel E.; Ly, Danith, Stabilized STAT3 decoy oligonucleotides and uses therefor.
  702. Grandis, Jennifer R.; Johnson, Daniel; Ly, Danith, Stabilized STAT3 decoy oligonucleotides and uses therefor.
  703. Grandis, Jennifer R.; Johnson, Daniel; Ly, Danith, Stabilized STAT3 decoy oligonucleotides and uses therefore.
  704. Rehder, Douglas; Bondarenko, Pavel; Chelius, Dirk; McAuley, Arnold; Matsumura, Masazumi, Stable polypeptide formulations.
  705. Rehder, Douglas; Bondarenko, Pavel; Chelius, Dirk; McAuley, Arnold; Matsumura, Masazumi, Stable polypeptide formulations.
  706. Hartmann, Gunther; Hornung, Veit, Structure and use of 5′ phosphate oligonucleotides.
  707. Hartmann, Gunther; Hornung, Veit, Structure and use of 5′ phosphate oligonucleotides.
  708. LeBowitz,Jonathan H.; Beverley,Stephen M., Subcellular targeting of therapeutic proteins.
  709. Ali, Syed M.; Ashwell, Mark A.; Hill, Jason; Lapierre, Jean-Marc; Moussa, Magdi; Namdev, Nivedita; Nicewonger, Robert; Tandon, Manish; Yang, Rui-Yang, Substituted 1H-pyrazolo[3,4-D]pyrimidine-6-amine compounds.
  710. Ali, Syed; Ashwell, Mark; Tandon, Manish; Namdev, Nivedita; Lapierre, Jean-Marc; Westlund, Neil; Palma, Rocio; Yang, Rui-Yang; Liu, Yanbin; Vensel, David; Eathiraj, Sudharshan; Wu, Hui; Kelleher, Eugene, Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds.
  711. John,Varghese; Hom,Roy; Tucker,John, Substituted alcohols useful in treatment of Alzheimer's disease.
  712. Chen,Dawei; Deshpande,Milind; Thurkauf,Andrew; Phadke,Avinash; Wang,Xiangzhu; Shen,Yiping; Liu,Cuixian; Quinn,Jesse; Ohkanda,Junko; Li,Shouming, Substituted aryl thioureas and related compounds; inhibitors of viral replication.
  713. Chen,Dawei; Deshpande,Milind; Thurkauf,Andrew; Phadke,Avinash; Wang,Xiangzhu; Shen,Yiping; Liu,Cuixian; Quinn,Jesse; Ohkanda,Junko; Li,Shouming, Substituted aryl thioureas and related compounds; inhibitors of viral replication.
  714. Ali, Syed M.; Ashwell, Mark A.; Kelleher, Eugene; Koerner, Steffi; Lapierre, Jean-Marc; Link, Jeffrey S.; Liu, Yanbin; Moussa, Magdi; Palma, Rocio; Tandon, Manish; Vensel, David; Westlund, Neil; Wu, Hui; Yang, Rui-Yang, Substituted benzo-pyrido-triazolo-diazepine compounds.
  715. Yang, Rui-Yang; Link, Jeffrey S., Substituted benzo-pyrimido-tetrazolo-diazepine compounds.
  716. Ashwell, Mark A.; Eathiraj, Sudharshan; Filikov, Anton; Koerner, Steffi; Lapierre, Jean-Marc; Liu, Yanbin; Palma, Rocio; Vensel, David; Iimura, Shin; Shiina, Akiko; Yoshida, Kenichi; Yamazaki, Takanori; Matsuda, Akihisa, Substituted benzo[f]lmidazo[1,2-d]pyrido[2,3-b][1,4]diazepine compounds.
  717. Tandon, Manish; Liu, Yanbin; Namdev, Nivedita; Ashwell, Mark A.; Palma, Rocio, Substituted dipyrido-pyrimido-diazepine and benzo-pyrido-pyrimido compounds.
  718. Ortega Muñoz, Alberto; Castro-Palomino Laria, Julio; Fyfe, Matthew Colin Thor, Substituted heteroaryl- and aryl-cyclopropylamine acetamides and their use.
  719. Ali, Syed M.; Ashwell, Mark A.; Liu, Yanbin; Moussa, Magdi; Wang, Jianqiang; Wu, Hui, Substituted heterocyclic compounds.
  720. Nicewonger, Robert; Dalton, Audra; Brassard, Chris; Ashwell, Mark A.; Palma, Rocio, Substituted heterocyclic compounds.
  721. John, Varghese; Maillard, Michel; Tucker, John; Aquino, Jose; Jagodzinska, Barbara; Brogley, Louis; Tung, Jay S.; Bowers, Simeon; Dressen, Darren; Probst, Gary; Shah, Neerav, Substituted hydroxyethylamine aspartyl protease inhibitors.
  722. Tun, Han W.; Yoshimitsu, Takehiko; Shigeoka, Daisuke; Kamon, Takuma; Li, Zhimin; Qiu, Yushi; Caulfield, Thomas R., Substituted imidazo[4',5':4,5]cyclopenta[1,2-e]pyrrolo[1,2-a]pyrazines and oxazolo[4',5':4,5]cyclopenta[1,2-e]pyrrolo[1,2-a]pyrazines for treating brain cancer.
  723. Ali, Syed M.; Ashwell, Mark A.; Brassard, Chris; Dalton, Audra; Filikov, Anton; Hill, Jason; Namdev, Nivedita; Palma, Rocio; Tandon, Manish; Vensel, David; Wang, Jianqiang; Westlund, Neil, Substituted imidazolyl-5,6-dihydrobenzo[N]isoquinoline compounds.
  724. Ashwell, Mark A.; Brassard, Chris; Filikov, Anton; Hill, Jason; Koerner, Steffi; Lapierre, Jean-Marc; Liu, Yanbin; Namdev, Nivedita; Nicewonger, Robert; Palma, Rocio; Tandon, Manish; Vensel, David; Matsuda, Akihisa; Iimura, Shin; Yamamoto, Yuko; Isoyama, Takeshi, Substituted imidazopyridinyl compounds.
  725. Ashwell, Mark A.; Brassard, Chris; Filikov, Anton; Hill, Jason; Koerner, Steffi; Lapierre, Jean-Marc; Liu, Yanbin; Namdev, Nivedita; Nicewonger, Robert; Palma, Rocio; Tandon, Manish; Vensel, David; Matsuda, Akihisa; Iimura, Shin; Yamamoto, Yuko, Substituted imidazopyridinyl-aminopyridine compounds.
  726. Ashwell, Mark A.; Brassard, Chris; Filikov, Anton; Hill, Jason; Koerner, Steffi; Lapierre, Jean-Marc; Liu, Yanbin; Namdev, Nivedita; Nicewonger, Robert; Palma, Rocio; Tandon, Manish; Vensel, David; Matsuda, Akihisa; Iimura, Shin; Yoshida, Kenichi; Yamazaki, Takanori; Kitamura, Takahiro; Isoyama, Takeshi, Substituted imidazopyridinyl-aminopyridine compounds.
  727. Ashwell, Mark A.; Brassard, Chris; Filikov, Anton; Hill, Jason; Koerner, Steffi; Lapierre, Jean-Marc; Liu, Yanbin; Namdev, Nivedita; Nicewonger, Robert; Palma, Rocio; Tandon, Manish; Vensel, David; Matsuda, Akihisa; Iimura, Shin; Yoshida, Kenichi; Yamazaki, Takanori; Kitamura, Takahiro; Isoyama, Takeshi, Substituted imidazopyridinyl-aminopyridine compounds.
  728. Zhang, Jian; Cook, Robert O.; Armer, Thomas A.; Kosarev, Sergey Alexandrovich; Xie, Dejian, Substituted indolo 4,3 FG quinolines useful for treating migraine.
  729. Tandon, Manish; Nicewonger, Robert, Substituted indolo-piperidine compounds.
  730. Namdev, Nivedita; Tandon, Manish; Wang, Jianqiang; Dalton, Audra; Vensel, David; Palma, Rocio; Ashwell, Mark A.; Westlund, Neil, Substituted indolo-pyridinone compounds.
  731. Ashwell, Mark A.; Brassard, Chris; Dalton, Audra; Hill, Jason; Nicewonger, Robert; Vensel, David, Substituted naphthalenyl-pyrimidine compounds.
  732. Chan Ming Fai ; Balaji Vitukudi Narayanaiyengar ; Castillo Rosario Silvestre ; Kois Adam ; Raju Bore Gowda ; Wu Chengde, Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin.
  733. Chan Ming Fai ; Balaji Vitukudi Narayanaiyengar ; Castillo Rosario Silvestre ; Kois Adam ; Raju Bore Gowda ; Wu Chengde, Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin.
  734. Tandon, Manish; Wang, Jianqiang; Namdev, Nivedita, Substituted pyrazolo-pyrimidine compounds.
  735. Hill, Jason; Tandon, Manish; Namdev, Nivedita; Palma, Rocio; Westlund, Neil; Filikov, Anton, Substituted pyrazolo-pyrrolo-pyridine-dione compounds.
  736. Liu, Yanbin; Namdev, Nivedita; Palma, Rocio; Tandon, Manish; Wang, Jianqiang; Wu, Hui, Substituted pyrrolo-aminopyrimidine compounds.
  737. Westlund, Neil, Substituted triazolo-pyrazine compounds.
  738. Ali, Syed M., Substituted triazolo-pyrimidine compounds.
  739. Pulley,Shon R.; Tucker,John A., Substituted ureas and carbamates.
  740. Wu, Chengde; Blok, Natalie; Holland, George W., Sulfonamides and derivatives thereof that modulate the activity of endothelin.
  741. Wu, Chengde; Raju, Bore Gowda; Kogan, Timothy; Blok, Natalie; Woodard, Patricia, Sulfonamides and derivatives thereof that modulate the activity of endothelin.
  742. Chengde Wu ; Natalie Blok ; Timothy Kogan ; Karin Keller ; Patricia Woodard, Sulfonamides for treatment of endothelin-mediated disorders.
  743. Wu, Chengde; Blok, Natalie; Kogan, Timothy; Keller, Karin, Sulfonamides for treatment of endothelin-mediated disorders.
  744. Suslick,Kenneth S.; Toublan,Farah Jean Jacques; Boppart,Stephen A.; Marks,Daniel L., Surface modified protein microparticles.
  745. Kashyap, Arun K.; Bhatt, Ramesh R.; Horowitz, Michael; Horowitz, Lawrence; Zhou, Sihong; O'Neil, Ryann E.; Hannum, Charles H.; Kurtzman, Aaron L.; Xu, Li, Surrogate binding proteins which bind DR4 and/or DR5.
  746. Alhamadsheh, Mamoun M.; Park, Miki S.; Chan, William K.; Li, Xiaoling; Penchala, Sravan C.; Miller, Mark R., Systems for stabilizing and delivering active agents.
  747. Fox, Judith A.; Rashid, M. Harunur; Roberge, Martin; Schellenberger, Volker, TAB molecules.
  748. Fox, Judith A.; Rashid, M. Harunur; Roberge, Martin; Schellenberger, Volker, Tab molecules.
  749. Mao,Chengjian; Shapiro,David J., Tamoxifen and 4-hydroxytamoxifen-activated system for regulated production of proteins in eukaryotic cells.
  750. Roth, Laurence A.; Herman, Stephen Jack, Targeted delivery via biodegradable polymers.
  751. Langer Robert S. ; Chen Hongming, Targeted polymerized liposomes for improved drug delivery.
  752. Church,George M.; Janse,Daniel M., Targeted polypeptide degradation.
  753. LeBowitz, Jonathan H.; Beverley, Stephen M., Targeted therapeutic proteins.
  754. LeBowitz, Jonathan H.; Beverley, Stephen M.; Sly, William S., Targeted therapeutic proteins.
  755. LeBowitz, Jonathan H.; Beverley, Stephen M.; Sly, William S., Targeted therapeutic proteins.
  756. LeBowitz, Jonathan; Beverley, Stephen M., Targeted therapeutic proteins.
  757. LeBowitz, Jonathan; Beverley, Stephen M., Targeted therapeutic proteins.
  758. LeBowitz, Jonathan; Beverley, Stephen M., Targeted therapeutic proteins.
  759. LeBowitz, Jonathan; Beverley, Stephen M.; Sly, William S., Targeted therapeutic proteins.
  760. John,Varghese; Tung,Jay; Fang,Lawrence; Mamo,Shumeye S., Tetrapeptide inhibitors of β-secretase.
  761. Faure, Gilbert; Gibot, Sebastien; Panina, Paola; Passini, Nadia, Therapeutic TREM-1 peptides.
  762. Chen, Yu; Chen, Yi, Therapeutic agents.
  763. Brown, Tracey J.; Brownlee, Gary R., Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment.
  764. Anderson, David W.; Alsobrook II, John P.; Boldog, Ferenc L.; Burgess, Catherine E.; Casman, Stacie J.; Edinger, Shlomit R.; Gangolli, Esha A.; Gorman, Linda; Guo, Xiaojia Sasha; Khramtsov, Nikolai; , Therapeutic polypeptides, nucleic acids encoding same, and methods of use.
  765. Brown, Tracey J., Therapeutic protocols using hyaluronan.
  766. Cheruvallath,Zacharia S.; Loweth,Colin J.; Nutt,Ruth F.; Rideout,Darryl; Semple,Joseph E.; Wang,Jing; Wu,Feiyue; Mylvaganam,Shankari; Zhu,Hengyi; Sun,Jianzhong, Thiazole and thiadiazole inhibitors of tyrosine phosphatases.
  767. Verner Erik Joel, Thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin.
  768. Verner Erik Joel, Thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin.
  769. Burgan,Raymond John; Goodwin,Ted Ernest; Vervacke,Steven Lawrence, Token array and method employing authentication tokens bearing scent formulation information.
  770. Milan, David J.; Peal, David S., Treating long QT syndrome.
  771. Medford Russell M. ; Alexander R. Wayne ; Offermann Margaret K., Treatment for atherosclerosis and other cardiovascular and inflammatory diseases.
  772. Medford Russell M. ; Alexander R. Wayne ; Parthasarathy Sampath ; Khan Bobby V., Treatment for atherosclerosis and other cardiovascular and inflammatory diseases.
  773. Medford Russell M. ; Alexander R. Wayne ; Parthasarathy Sampath ; Khan Bobby V., Treatment for atherosclerosis and other cardiovascular and inflammatory diseases.
  774. Medford Russell M. ; Alexander R. Wayne ; Parthasarathy Sampath ; Khan Bobby V., Treatment for atherosclerosis and other cardiovascular and inflammatory diseases.
  775. Medford Russell M. ; Offermann Margaret K. ; Alexander R. Wayne, Treatment for atherosclerosis and other cardiovascular and inflammatory diseases.
  776. Medford Russell M. ; Offermann Margaret K. ; Alexander R. Wayne ; Parthasarathy Sampath, Treatment for atherosclerosis and other cardiovascular and inflammatory diseases.
  777. Medford Russell M. ; Offermann Margaret K. ; Alexander R. Wayne ; Parthasarathy Sampath, Treatment for atherosclerosis and other cardiovascular and inflammatory diseases.
  778. Freeman William R., Treatment of conditions of abnormally increased intraocular pressure by administration of phosphonylmethoxyalkyl nucleos.
  779. Freeman William R., Treatment of conditions of abnormally increased intraocular pressure by administration of phosphonylmethoxyalkyl nucleoside analogs and related nucleoside analogs.
  780. Constable, Ian J.; Rakoczy, P. Elizabeth; Lai, Chooi-May; Chalberg, Jr., Thomas W., Treatment of ocular neovascularization using anti-VEGF proteins.
  781. Constable, Ian J.; Rakoczy, P. Elizabeth; Lai, Chooi-May; Chalberg, Jr., Thomas W., Treatment of ocular neovascularization using anti-VEGF proteins.
  782. McMinn, Dustin; Johnson, Henry; Bowers, Simeon; Moebius, David C., Tripeptide epoxy ketone protease inhibitors.
  783. Venkatesan, Hariharan; Snyder, James P.; Liotta, Dennis C.; Wang, Susheng, Triptolide analogs for the treatment of autoimmune and inflammatory disorders.
  784. Wang, Susheng; Liotta, Dennis C.; Snyder, James P.; Venkatesan, Hariharan, Triptolide analogs for the treatment of autoimmune and inflammatory disorders.
  785. Wang, Susheng; Liotta, Dennis C.; Snyder, James P.; Venkatesan, Hariharan, Triptolide analogs for the treatment of autoimmune and inflammatory disorders.
  786. Drapeau, Denis; Snow, Jessica; Hiller, Gregory; Luan, Yen Tung, Use of copper and glutamate in cell culture for production of polypeptides.
  787. Verner Erik Joel, Use of thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin.
  788. Timmer, John C.; Eckelman, Brendan P.; Guenther, Grant B.; Nguy, Peter L.; Chan, Henry; Deveraux, Quinn, WAP domain fusion polypeptides and methods of use thereof.
  789. Timmer, John; Eckelman, Brendan; Guenther, Grant B.; Nguy, Peter L.; Chan, Henry; Deveraux, Quinn, WAP domain fusion polypeptides and methods of use thereof.
  790. Pandey, Ravindra K.; Gryshuk, Amy; Goswami, Lalit; Potter, William; Oseroff, Allan, Water soluble tetrapyrollic photosensitizers for photodynamic therapy.
  791. Pandey,Ravindra K.; Gryshuk,Amy; Goswami,Lalit; Potter,William; Oseroff,Allan, Water soluble tetrapyrollic photosensitizers for photodynamic therapy.
  792. Yusibov, Vidadi; Mett, Vadim; Musiychuk, Konstantin, Yersinia pestis antigens, vaccine compositions, and related methods.
  793. Landgraf, Kyle E.; Lazarus, Robert A., Zymogen activators.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로